Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Asthma | 491 | 2024 | 6011 | 23.820 |
Why?
|
Vitamin D | 75 | 2024 | 3223 | 7.460 |
Why?
|
Anti-Asthmatic Agents | 48 | 2023 | 536 | 5.350 |
Why?
|
Respiratory Sounds | 58 | 2024 | 696 | 5.180 |
Why?
|
Forced Expiratory Volume | 149 | 2023 | 1743 | 4.650 |
Why?
|
Pharmacogenetics | 33 | 2016 | 675 | 3.970 |
Why?
|
Polymorphism, Single Nucleotide | 152 | 2023 | 15519 | 3.830 |
Why?
|
Genome-Wide Association Study | 99 | 2023 | 12261 | 3.610 |
Why?
|
Adrenal Cortex Hormones | 43 | 2023 | 1855 | 3.200 |
Why?
|
Hypersensitivity | 43 | 2023 | 1102 | 3.170 |
Why?
|
Bronchial Hyperreactivity | 45 | 2017 | 319 | 3.150 |
Why?
|
Hypersensitivity, Immediate | 33 | 2023 | 337 | 3.040 |
Why?
|
Lung | 107 | 2024 | 9856 | 3.000 |
Why?
|
Bronchodilator Agents | 40 | 2022 | 502 | 2.970 |
Why?
|
Pre-Eclampsia | 10 | 2023 | 1200 | 2.880 |
Why?
|
Vitamins | 22 | 2024 | 1622 | 2.690 |
Why?
|
Vitamin D Deficiency | 23 | 2024 | 1343 | 2.620 |
Why?
|
Genetic Predisposition to Disease | 110 | 2023 | 17446 | 2.420 |
Why?
|
Immunoglobulin E | 62 | 2023 | 1463 | 2.380 |
Why?
|
Vital Capacity | 67 | 2023 | 925 | 2.280 |
Why?
|
Respiratory Function Tests | 61 | 2023 | 1616 | 2.230 |
Why?
|
Bronchi | 35 | 2020 | 840 | 2.180 |
Why?
|
Lung Diseases, Obstructive | 38 | 2001 | 316 | 2.170 |
Why?
|
Methacholine Chloride | 38 | 2017 | 233 | 1.950 |
Why?
|
Polymorphism, Genetic | 41 | 2016 | 4328 | 1.890 |
Why?
|
Prenatal Exposure Delayed Effects | 23 | 2023 | 2408 | 1.860 |
Why?
|
Adrenergic beta-Agonists | 23 | 2014 | 346 | 1.830 |
Why?
|
Phenotype | 96 | 2023 | 16365 | 1.820 |
Why?
|
Humans | 991 | 2024 | 744343 | 1.820 |
Why?
|
Dietary Supplements | 21 | 2024 | 3297 | 1.770 |
Why?
|
Child | 305 | 2024 | 77709 | 1.740 |
Why?
|
Receptors, Adrenergic, beta-2 | 20 | 2015 | 202 | 1.720 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 34 | 2023 | 3047 | 1.710 |
Why?
|
Allergens | 48 | 2022 | 1320 | 1.700 |
Why?
|
Aneurysm, Ruptured | 14 | 2021 | 452 | 1.660 |
Why?
|
Smoking | 131 | 2022 | 8987 | 1.650 |
Why?
|
Genotype | 88 | 2023 | 12951 | 1.640 |
Why?
|
Pregnancy | 102 | 2024 | 29144 | 1.630 |
Why?
|
Eczema | 15 | 2022 | 231 | 1.620 |
Why?
|
Bronchial Provocation Tests | 51 | 2016 | 227 | 1.610 |
Why?
|
Female | 574 | 2024 | 380194 | 1.570 |
Why?
|
Genome, Human | 30 | 2021 | 4420 | 1.530 |
Why?
|
Linkage Disequilibrium | 36 | 2021 | 1997 | 1.510 |
Why?
|
Budesonide | 22 | 2020 | 154 | 1.510 |
Why?
|
MicroRNAs | 16 | 2024 | 3752 | 1.510 |
Why?
|
Intracranial Aneurysm | 17 | 2021 | 1197 | 1.510 |
Why?
|
Cholecalciferol | 6 | 2019 | 537 | 1.510 |
Why?
|
Male | 610 | 2023 | 350118 | 1.500 |
Why?
|
Aging | 75 | 2021 | 8664 | 1.480 |
Why?
|
Child, Preschool | 161 | 2024 | 41006 | 1.460 |
Why?
|
Administration, Inhalation | 45 | 2022 | 1105 | 1.410 |
Why?
|
Skin Tests | 46 | 2016 | 613 | 1.390 |
Why?
|
Nedocromil | 17 | 2019 | 46 | 1.360 |
Why?
|
Gene Expression Profiling | 27 | 2024 | 9438 | 1.330 |
Why?
|
Prenatal Care | 5 | 2020 | 1092 | 1.290 |
Why?
|
Genetic Variation | 40 | 2022 | 6544 | 1.260 |
Why?
|
Sphingolipids | 5 | 2023 | 159 | 1.230 |
Why?
|
Leukotriene Antagonists | 11 | 2015 | 127 | 1.230 |
Why?
|
Respiratory Tract Diseases | 16 | 2016 | 722 | 1.210 |
Why?
|
Fetal Blood | 15 | 2023 | 1318 | 1.150 |
Why?
|
Anti-Inflammatory Agents | 22 | 2017 | 1790 | 1.130 |
Why?
|
Premature Birth | 5 | 2023 | 1721 | 1.110 |
Why?
|
Haplotypes | 34 | 2021 | 2779 | 1.090 |
Why?
|
Hygiene | 5 | 2015 | 98 | 1.090 |
Why?
|
Adult | 376 | 2023 | 214055 | 1.080 |
Why?
|
Genetic Linkage | 21 | 2008 | 2421 | 1.080 |
Why?
|
Epithelial Cells | 9 | 2022 | 3690 | 1.060 |
Why?
|
Gene Frequency | 37 | 2021 | 3588 | 1.060 |
Why?
|
Tobacco Smoke Pollution | 25 | 2011 | 816 | 1.040 |
Why?
|
Receptors, Corticotropin-Releasing Hormone | 5 | 2009 | 87 | 1.010 |
Why?
|
Genomics | 22 | 2024 | 5720 | 0.980 |
Why?
|
Lead | 22 | 2021 | 852 | 0.970 |
Why?
|
Spirometry | 41 | 2022 | 864 | 0.960 |
Why?
|
Gene Regulatory Networks | 16 | 2024 | 1708 | 0.960 |
Why?
|
Bronchoconstrictor Agents | 14 | 2016 | 77 | 0.950 |
Why?
|
Airway Resistance | 6 | 2020 | 404 | 0.920 |
Why?
|
Respiratory Hypersensitivity | 16 | 2023 | 274 | 0.910 |
Why?
|
Environmental Exposure | 35 | 2023 | 4234 | 0.900 |
Why?
|
Eosinophils | 21 | 2023 | 955 | 0.880 |
Why?
|
Metalloendopeptidases | 5 | 2004 | 396 | 0.870 |
Why?
|
DNA Methylation | 17 | 2023 | 4286 | 0.840 |
Why?
|
Respiratory System | 5 | 2018 | 557 | 0.840 |
Why?
|
Cross-Cultural Comparison | 9 | 2000 | 651 | 0.830 |
Why?
|
Software | 17 | 2023 | 4443 | 0.830 |
Why?
|
Interleukin-13 | 9 | 2011 | 389 | 0.830 |
Why?
|
Developmental Disabilities | 3 | 2020 | 1456 | 0.830 |
Why?
|
Adolescent | 191 | 2022 | 85781 | 0.820 |
Why?
|
Computational Biology | 12 | 2020 | 3521 | 0.790 |
Why?
|
Case-Control Studies | 64 | 2021 | 21746 | 0.780 |
Why?
|
Dermatitis, Atopic | 9 | 2023 | 654 | 0.770 |
Why?
|
Lung Diseases | 15 | 2018 | 1886 | 0.760 |
Why?
|
Eosinophilia | 11 | 2020 | 541 | 0.760 |
Why?
|
Metabolomics | 11 | 2024 | 1484 | 0.750 |
Why?
|
Cohort Studies | 113 | 2023 | 40561 | 0.750 |
Why?
|
Chromosome Mapping | 21 | 2018 | 4740 | 0.750 |
Why?
|
Food Hypersensitivity | 4 | 2022 | 622 | 0.740 |
Why?
|
Albuterol | 17 | 2018 | 208 | 0.740 |
Why?
|
Middle Aged | 286 | 2023 | 213383 | 0.730 |
Why?
|
Longitudinal Studies | 97 | 2017 | 13989 | 0.730 |
Why?
|
Leukocyte Count | 24 | 2018 | 1588 | 0.730 |
Why?
|
Alcohol Drinking | 23 | 2022 | 3966 | 0.720 |
Why?
|
Chromosomes, Human, Pair 12 | 5 | 2011 | 462 | 0.710 |
Why?
|
Double-Blind Method | 40 | 2022 | 12026 | 0.710 |
Why?
|
Risk Factors | 138 | 2023 | 72290 | 0.710 |
Why?
|
Costa Rica | 19 | 2019 | 177 | 0.700 |
Why?
|
Gene Expression Regulation | 28 | 2024 | 12072 | 0.700 |
Why?
|
Genetic Loci | 14 | 2023 | 2575 | 0.690 |
Why?
|
Pregnancy Trimester, First | 6 | 2021 | 853 | 0.680 |
Why?
|
Systems Biology | 4 | 2018 | 469 | 0.680 |
Why?
|
Respiratory Mechanics | 11 | 2015 | 686 | 0.680 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 6 | 2015 | 104 | 0.670 |
Why?
|
Muscle, Smooth | 6 | 2015 | 934 | 0.660 |
Why?
|
Receptors, IgE | 3 | 2011 | 389 | 0.660 |
Why?
|
Pregnancy Complications | 8 | 2023 | 2861 | 0.660 |
Why?
|
Airway Remodeling | 1 | 2020 | 132 | 0.650 |
Why?
|
Stress, Mechanical | 3 | 2022 | 1686 | 0.650 |
Why?
|
Bayes Theorem | 11 | 2022 | 2309 | 0.650 |
Why?
|
Genome | 5 | 2024 | 1808 | 0.650 |
Why?
|
Infant, Newborn | 51 | 2023 | 25625 | 0.640 |
Why?
|
Quantitative Trait Loci | 15 | 2022 | 2019 | 0.640 |
Why?
|
Alleles | 29 | 2021 | 6933 | 0.630 |
Why?
|
Autoimmune Diseases | 5 | 2014 | 2133 | 0.630 |
Why?
|
Jews | 8 | 1999 | 385 | 0.630 |
Why?
|
Pyroglyphidae | 4 | 2012 | 88 | 0.620 |
Why?
|
Disease | 2 | 2021 | 680 | 0.620 |
Why?
|
Receptors, Glucocorticoid | 4 | 2017 | 302 | 0.620 |
Why?
|
Body Mass Index | 42 | 2024 | 12720 | 0.620 |
Why?
|
Bronchoconstriction | 8 | 2016 | 143 | 0.620 |
Why?
|
RNA, Ribosomal, 16S | 7 | 2023 | 954 | 0.610 |
Why?
|
Feces | 8 | 2022 | 1401 | 0.610 |
Why?
|
Chromosomes, Human, Pair 17 | 4 | 2019 | 437 | 0.600 |
Why?
|
Infant, Premature | 7 | 2020 | 2044 | 0.600 |
Why?
|
Infant | 73 | 2024 | 35136 | 0.600 |
Why?
|
Obesity | 32 | 2023 | 12745 | 0.590 |
Why?
|
Cathelicidins | 1 | 2017 | 80 | 0.590 |
Why?
|
Receptors, Cell Surface | 9 | 2009 | 2866 | 0.590 |
Why?
|
Pregnancy Trimester, Third | 2 | 2016 | 571 | 0.590 |
Why?
|
Metabolome | 7 | 2023 | 895 | 0.580 |
Why?
|
Maternal Exposure | 9 | 2020 | 961 | 0.580 |
Why?
|
Gene Expression | 12 | 2020 | 7799 | 0.580 |
Why?
|
Vulnerable Populations | 1 | 2022 | 687 | 0.570 |
Why?
|
Algorithms | 30 | 2024 | 13881 | 0.570 |
Why?
|
Religion and Psychology | 6 | 1995 | 171 | 0.570 |
Why?
|
Genetic Testing | 17 | 2022 | 3444 | 0.560 |
Why?
|
Models, Genetic | 26 | 2022 | 3494 | 0.560 |
Why?
|
Regression Analysis | 50 | 2013 | 6459 | 0.560 |
Why?
|
Linear Models | 31 | 2024 | 5952 | 0.560 |
Why?
|
Dust | 6 | 2015 | 482 | 0.550 |
Why?
|
Aged | 201 | 2022 | 163280 | 0.550 |
Why?
|
Proteins | 10 | 2020 | 6103 | 0.550 |
Why?
|
Epigenesis, Genetic | 10 | 2023 | 3647 | 0.550 |
Why?
|
T-Box Domain Proteins | 4 | 2019 | 471 | 0.550 |
Why?
|
Bacteria | 8 | 2020 | 2114 | 0.540 |
Why?
|
Islam | 7 | 1997 | 69 | 0.540 |
Why?
|
Cytokines | 17 | 2023 | 7322 | 0.530 |
Why?
|
Pneumonia | 4 | 2024 | 2133 | 0.530 |
Why?
|
Membrane Proteins | 11 | 2019 | 7880 | 0.530 |
Why?
|
Antigens, Dermatophagoides | 12 | 2017 | 100 | 0.520 |
Why?
|
Angiopoietin-1 | 1 | 2015 | 114 | 0.520 |
Why?
|
Steroids | 11 | 2021 | 930 | 0.520 |
Why?
|
Prospective Studies | 82 | 2023 | 53288 | 0.520 |
Why?
|
Pedigree | 19 | 2020 | 4644 | 0.510 |
Why?
|
Models, Biological | 15 | 2016 | 9583 | 0.510 |
Why?
|
Genetics, Population | 7 | 2021 | 934 | 0.500 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 4 | 2023 | 88 | 0.500 |
Why?
|
Fatty Acids, Omega-3 | 2 | 2023 | 1344 | 0.500 |
Why?
|
Glucocorticoids | 10 | 2017 | 2107 | 0.500 |
Why?
|
Leukocytes, Mononuclear | 11 | 2020 | 1836 | 0.490 |
Why?
|
Genetic Association Studies | 13 | 2021 | 2703 | 0.490 |
Why?
|
Hydroxyurea | 3 | 2018 | 290 | 0.490 |
Why?
|
Genes, Developmental | 1 | 2014 | 40 | 0.480 |
Why?
|
Nuclear Family | 8 | 2008 | 318 | 0.480 |
Why?
|
Health Surveys | 12 | 2009 | 4037 | 0.480 |
Why?
|
Animals | 112 | 2024 | 168757 | 0.480 |
Why?
|
Air Pollution, Indoor | 11 | 2020 | 857 | 0.480 |
Why?
|
Hostility | 4 | 2006 | 189 | 0.470 |
Why?
|
Neoplasm Proteins | 7 | 2020 | 3703 | 0.470 |
Why?
|
Biological Specimen Banks | 5 | 2021 | 711 | 0.470 |
Why?
|
Sarcoma, Experimental | 1 | 2013 | 128 | 0.470 |
Why?
|
Coronary Disease | 15 | 2002 | 6077 | 0.470 |
Why?
|
MMPI | 4 | 2003 | 86 | 0.470 |
Why?
|
Receptors, Interleukin-8B | 1 | 2013 | 59 | 0.470 |
Why?
|
Sex Characteristics | 11 | 2016 | 2585 | 0.460 |
Why?
|
Subarachnoid Hemorrhage | 5 | 2019 | 1018 | 0.460 |
Why?
|
Salmonidae | 2 | 2003 | 13 | 0.460 |
Why?
|
Severity of Illness Index | 47 | 2020 | 15540 | 0.460 |
Why?
|
Respiratory Insufficiency | 4 | 2022 | 1199 | 0.460 |
Why?
|
Interleukin-10 | 8 | 2009 | 1200 | 0.450 |
Why?
|
Mothers | 11 | 2023 | 2165 | 0.450 |
Why?
|
Integrin beta Chains | 1 | 2013 | 121 | 0.450 |
Why?
|
Endophenotypes | 1 | 2015 | 250 | 0.450 |
Why?
|
Randomized Controlled Trials as Topic | 16 | 2022 | 9959 | 0.450 |
Why?
|
Kv Channel-Interacting Proteins | 1 | 2013 | 56 | 0.450 |
Why?
|
Rhinovirus | 4 | 2018 | 187 | 0.440 |
Why?
|
Cross-Sectional Studies | 67 | 2024 | 25043 | 0.440 |
Why?
|
Respiration | 9 | 2008 | 1653 | 0.440 |
Why?
|
Fetus | 4 | 2023 | 1880 | 0.440 |
Why?
|
NFATC Transcription Factors | 3 | 2020 | 381 | 0.430 |
Why?
|
Age Factors | 57 | 2021 | 18370 | 0.430 |
Why?
|
Diet | 20 | 2023 | 7939 | 0.430 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2013 | 165 | 0.430 |
Why?
|
Gestational Age | 12 | 2023 | 3493 | 0.420 |
Why?
|
Neoplasms, Experimental | 2 | 2015 | 1276 | 0.420 |
Why?
|
Incidence | 29 | 2020 | 20947 | 0.420 |
Why?
|
Area Under Curve | 6 | 2020 | 1654 | 0.420 |
Why?
|
Quantitative Trait, Heritable | 10 | 2008 | 544 | 0.420 |
Why?
|
Family | 20 | 2024 | 3147 | 0.420 |
Why?
|
Th2 Cells | 6 | 2024 | 1061 | 0.420 |
Why?
|
Genetic Markers | 22 | 2015 | 2634 | 0.420 |
Why?
|
Aged, 80 and over | 83 | 2021 | 57776 | 0.420 |
Why?
|
Models, Statistical | 16 | 2021 | 5102 | 0.420 |
Why?
|
Salmonella typhimurium | 1 | 2014 | 351 | 0.410 |
Why?
|
Blood Pressure | 26 | 2014 | 8554 | 0.410 |
Why?
|
Cyprinidae | 1 | 2011 | 38 | 0.410 |
Why?
|
Rhinitis, Allergic, Seasonal | 7 | 2017 | 99 | 0.410 |
Why?
|
Aspirin | 4 | 2020 | 3282 | 0.410 |
Why?
|
Interferon-beta | 1 | 2013 | 323 | 0.410 |
Why?
|
Long-Term Care | 1 | 2015 | 607 | 0.410 |
Why?
|
China | 19 | 2021 | 2248 | 0.400 |
Why?
|
Regulatory Sequences, Nucleic Acid | 4 | 2011 | 794 | 0.400 |
Why?
|
Autophagy | 3 | 2017 | 1300 | 0.400 |
Why?
|
Fibrosarcoma | 1 | 2013 | 348 | 0.400 |
Why?
|
Maximal Midexpiratory Flow Rate | 7 | 2004 | 78 | 0.400 |
Why?
|
Air Pollutants | 6 | 2019 | 2817 | 0.400 |
Why?
|
Logistic Models | 41 | 2020 | 13408 | 0.400 |
Why?
|
Gene Expression Regulation, Developmental | 6 | 2016 | 3617 | 0.400 |
Why?
|
Multivariate Analysis | 43 | 2020 | 12245 | 0.400 |
Why?
|
Transcription, Genetic | 9 | 2021 | 7722 | 0.390 |
Why?
|
Receptors, Purinergic P2Y12 | 1 | 2012 | 132 | 0.390 |
Why?
|
Databases, Genetic | 9 | 2021 | 1783 | 0.390 |
Why?
|
Sequence Analysis, RNA | 9 | 2019 | 2012 | 0.390 |
Why?
|
Neutrophil Infiltration | 1 | 2013 | 390 | 0.390 |
Why?
|
Acetates | 3 | 2012 | 311 | 0.390 |
Why?
|
Interferon Regulatory Factors | 3 | 2019 | 270 | 0.390 |
Why?
|
Cystic Fibrosis | 4 | 2009 | 1177 | 0.390 |
Why?
|
Metagenomics | 4 | 2023 | 428 | 0.380 |
Why?
|
Mexican Americans | 6 | 2022 | 166 | 0.380 |
Why?
|
Respiratory Tract Infections | 14 | 2006 | 961 | 0.380 |
Why?
|
Anterior Cerebral Artery | 2 | 2021 | 48 | 0.380 |
Why?
|
Inflammation | 16 | 2024 | 10638 | 0.380 |
Why?
|
Odds Ratio | 27 | 2020 | 9849 | 0.380 |
Why?
|
Young Adult | 41 | 2021 | 56430 | 0.380 |
Why?
|
Host-Pathogen Interactions | 4 | 2017 | 1477 | 0.380 |
Why?
|
Receptors, Calcitriol | 4 | 2021 | 350 | 0.380 |
Why?
|
Child Development | 3 | 2023 | 2223 | 0.370 |
Why?
|
Virus Diseases | 3 | 2015 | 711 | 0.370 |
Why?
|
Principal Component Analysis | 7 | 2021 | 940 | 0.370 |
Why?
|
Gastrointestinal Tract | 2 | 2020 | 814 | 0.370 |
Why?
|
Body Constitution | 8 | 2001 | 278 | 0.370 |
Why?
|
Riluzole | 1 | 2010 | 55 | 0.370 |
Why?
|
Respiration Disorders | 7 | 1997 | 371 | 0.370 |
Why?
|
Research Design | 16 | 2015 | 5987 | 0.370 |
Why?
|
Epithelium | 3 | 2021 | 1679 | 0.370 |
Why?
|
Placenta | 6 | 2023 | 1698 | 0.370 |
Why?
|
Christianity | 4 | 1995 | 47 | 0.360 |
Why?
|
Melanoma, Experimental | 1 | 2013 | 561 | 0.360 |
Why?
|
Fetal Development | 5 | 2020 | 767 | 0.360 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2016 | 2282 | 0.360 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 6 | 2021 | 314 | 0.360 |
Why?
|
Treatment Outcome | 51 | 2020 | 63114 | 0.360 |
Why?
|
Multifactorial Inheritance | 4 | 2023 | 1194 | 0.360 |
Why?
|
Alcoholism | 9 | 1995 | 1906 | 0.360 |
Why?
|
Basilar Artery | 2 | 2021 | 200 | 0.360 |
Why?
|
Biofilms | 1 | 2014 | 617 | 0.350 |
Why?
|
Mice | 50 | 2024 | 81183 | 0.350 |
Why?
|
Atrial Natriuretic Factor | 2 | 2010 | 393 | 0.350 |
Why?
|
Cell Line | 22 | 2020 | 15997 | 0.350 |
Why?
|
Lipoxygenase Inhibitors | 2 | 2009 | 94 | 0.350 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2009 | 42 | 0.340 |
Why?
|
Natural Language Processing | 5 | 2020 | 1041 | 0.340 |
Why?
|
Membrane Glycoproteins | 7 | 2011 | 3768 | 0.340 |
Why?
|
Nurse-Patient Relations | 1 | 2009 | 101 | 0.340 |
Why?
|
Chondrogenesis | 2 | 2011 | 247 | 0.340 |
Why?
|
Cluster Analysis | 9 | 2022 | 2715 | 0.340 |
Why?
|
RNA-Binding Proteins | 2 | 2020 | 1903 | 0.340 |
Why?
|
ROC Curve | 7 | 2020 | 3527 | 0.340 |
Why?
|
Pseudomonas aeruginosa | 2 | 2014 | 1219 | 0.330 |
Why?
|
Interleukin-1 Receptor-Associated Kinases | 1 | 2009 | 78 | 0.330 |
Why?
|
Medical Records Systems, Computerized | 4 | 2009 | 1205 | 0.330 |
Why?
|
Karyopherins | 1 | 2009 | 137 | 0.330 |
Why?
|
Integrin beta3 | 1 | 2009 | 122 | 0.330 |
Why?
|
Helminthiasis | 2 | 2000 | 66 | 0.330 |
Why?
|
Multiple Organ Failure | 2 | 2022 | 390 | 0.320 |
Why?
|
Histamine | 13 | 2000 | 507 | 0.320 |
Why?
|
Insulin | 12 | 2000 | 6580 | 0.320 |
Why?
|
Parathyroid Hormone-Related Protein | 1 | 2010 | 331 | 0.320 |
Why?
|
Fluocinolone Acetonide | 2 | 2009 | 36 | 0.320 |
Why?
|
Follow-Up Studies | 55 | 2020 | 39050 | 0.320 |
Why?
|
Electronic Health Records | 7 | 2022 | 4468 | 0.320 |
Why?
|
Sodium Channels | 1 | 2010 | 349 | 0.320 |
Why?
|
Dexamethasone | 6 | 2018 | 1951 | 0.320 |
Why?
|
Arginase | 1 | 2008 | 79 | 0.320 |
Why?
|
RNA, Messenger | 17 | 2023 | 13033 | 0.320 |
Why?
|
Oxidative Stress | 2 | 2017 | 3086 | 0.320 |
Why?
|
Immunoglobulins | 1 | 2011 | 881 | 0.320 |
Why?
|
Sex Factors | 35 | 2016 | 10397 | 0.320 |
Why?
|
Vitamin E Deficiency | 1 | 2008 | 32 | 0.320 |
Why?
|
Israel | 16 | 1999 | 796 | 0.310 |
Why?
|
Drug Labeling | 1 | 2010 | 233 | 0.310 |
Why?
|
Reference Values | 22 | 2012 | 4982 | 0.310 |
Why?
|
Chromosome Inversion | 1 | 2008 | 127 | 0.310 |
Why?
|
Neutrophils | 5 | 2014 | 3719 | 0.310 |
Why?
|
Body Weight | 9 | 2011 | 4669 | 0.310 |
Why?
|
Recurrence | 17 | 2020 | 8340 | 0.310 |
Why?
|
Anti-Bacterial Agents | 6 | 2014 | 7181 | 0.310 |
Why?
|
Drug Resistance | 5 | 2019 | 1609 | 0.300 |
Why?
|
CpG Islands | 8 | 2021 | 1172 | 0.300 |
Why?
|
Picornaviridae Infections | 3 | 2017 | 88 | 0.300 |
Why?
|
Insulin Resistance | 6 | 1998 | 3864 | 0.300 |
Why?
|
Predictive Value of Tests | 29 | 2018 | 15076 | 0.300 |
Why?
|
Interleukin-1 | 2 | 2009 | 1263 | 0.300 |
Why?
|
Risk | 32 | 2020 | 9687 | 0.300 |
Why?
|
Respiratory Syncytial Virus Infections | 3 | 2019 | 329 | 0.300 |
Why?
|
Haploidy | 1 | 2007 | 136 | 0.300 |
Why?
|
Quinolines | 3 | 2012 | 732 | 0.300 |
Why?
|
Alcohol-Related Disorders | 2 | 2000 | 234 | 0.290 |
Why?
|
Methacholine Compounds | 5 | 1990 | 35 | 0.290 |
Why?
|
Chemokines, CC | 2 | 2006 | 291 | 0.290 |
Why?
|
Fatty Acids | 6 | 2023 | 1809 | 0.290 |
Why?
|
Promoter Regions, Genetic | 16 | 2017 | 5867 | 0.290 |
Why?
|
Inservice Training | 1 | 2009 | 392 | 0.290 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2010 | 476 | 0.290 |
Why?
|
Artificial Intelligence | 2 | 2011 | 2214 | 0.290 |
Why?
|
Data Interpretation, Statistical | 11 | 2019 | 2716 | 0.280 |
Why?
|
Germ-Line Mutation | 4 | 2023 | 1788 | 0.280 |
Why?
|
Circle of Willis | 3 | 2021 | 68 | 0.280 |
Why?
|
United States | 62 | 2023 | 69872 | 0.280 |
Why?
|
Attitude to Health | 3 | 2009 | 2052 | 0.280 |
Why?
|
Cell Adhesion Molecules | 3 | 2019 | 1602 | 0.280 |
Why?
|
Boston | 32 | 2016 | 9313 | 0.280 |
Why?
|
Base Sequence | 16 | 2023 | 12797 | 0.280 |
Why?
|
Clostridium Infections | 3 | 2023 | 548 | 0.280 |
Why?
|
Analysis of Variance | 20 | 2015 | 6365 | 0.280 |
Why?
|
Clinical Trials as Topic | 12 | 2023 | 7913 | 0.280 |
Why?
|
Nose | 2 | 2020 | 509 | 0.280 |
Why?
|
Family Health | 9 | 2006 | 1282 | 0.280 |
Why?
|
Placebos | 9 | 2017 | 1676 | 0.280 |
Why?
|
Endotoxins | 3 | 2004 | 527 | 0.270 |
Why?
|
Physician-Patient Relations | 3 | 2009 | 3229 | 0.270 |
Why?
|
Disease Susceptibility | 5 | 2019 | 1782 | 0.270 |
Why?
|
Sepsis | 4 | 2022 | 2593 | 0.270 |
Why?
|
Lectins, C-Type | 1 | 2009 | 588 | 0.270 |
Why?
|
Forkhead Transcription Factors | 3 | 2020 | 1613 | 0.270 |
Why?
|
Lod Score | 8 | 2006 | 614 | 0.270 |
Why?
|
C-Reactive Protein | 7 | 2023 | 3778 | 0.270 |
Why?
|
Interferons | 3 | 2022 | 706 | 0.270 |
Why?
|
Fish Oils | 2 | 2019 | 470 | 0.270 |
Why?
|
RNA, Bacterial | 2 | 2019 | 390 | 0.270 |
Why?
|
Sunlight | 1 | 2007 | 325 | 0.270 |
Why?
|
Wnt Proteins | 1 | 2009 | 721 | 0.260 |
Why?
|
Computer Simulation | 19 | 2023 | 6196 | 0.260 |
Why?
|
Interleukin-9 | 2 | 2016 | 63 | 0.260 |
Why?
|
Communication | 1 | 2019 | 3749 | 0.260 |
Why?
|
Managed Care Programs | 6 | 2005 | 950 | 0.260 |
Why?
|
Lymphotoxin-alpha | 1 | 2005 | 96 | 0.260 |
Why?
|
Temperance | 2 | 1995 | 89 | 0.260 |
Why?
|
Ascorbic Acid | 5 | 2005 | 651 | 0.260 |
Why?
|
Chromosomes, Human | 3 | 2018 | 457 | 0.260 |
Why?
|
Breast Feeding | 9 | 2018 | 1338 | 0.260 |
Why?
|
beta-Defensins | 1 | 2005 | 57 | 0.260 |
Why?
|
Epidemics | 1 | 2011 | 523 | 0.250 |
Why?
|
Lead Poisoning | 6 | 2003 | 301 | 0.250 |
Why?
|
Chondrocytes | 1 | 2010 | 804 | 0.250 |
Why?
|
Cardiovascular Diseases | 16 | 2023 | 15165 | 0.250 |
Why?
|
Respiration, Artificial | 1 | 2015 | 2569 | 0.250 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2022 | 1676 | 0.250 |
Why?
|
Quantum Dots | 2 | 2009 | 172 | 0.250 |
Why?
|
Folic Acid | 4 | 2017 | 1300 | 0.240 |
Why?
|
Cerebral Angiography | 5 | 2021 | 1285 | 0.240 |
Why?
|
Cotinine | 5 | 2022 | 206 | 0.240 |
Why?
|
Microsatellite Repeats | 4 | 2011 | 802 | 0.240 |
Why?
|
Interferon-gamma | 6 | 2006 | 3206 | 0.240 |
Why?
|
Interleukin-12 Subunit p40 | 2 | 2019 | 55 | 0.240 |
Why?
|
ADAM Proteins | 6 | 2007 | 243 | 0.240 |
Why?
|
Dietary Fats | 4 | 2018 | 2017 | 0.240 |
Why?
|
Physical Examination | 2 | 2004 | 1237 | 0.240 |
Why?
|
Sample Size | 6 | 2023 | 845 | 0.240 |
Why?
|
Caffeine | 2 | 2022 | 699 | 0.230 |
Why?
|
Multigene Family | 3 | 2005 | 1102 | 0.230 |
Why?
|
Internet | 4 | 2014 | 3064 | 0.230 |
Why?
|
Models, Theoretical | 13 | 2020 | 3589 | 0.230 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2020 | 2938 | 0.230 |
Why?
|
Prevalence | 23 | 2022 | 15226 | 0.230 |
Why?
|
Reproducibility of Results | 17 | 2024 | 19905 | 0.230 |
Why?
|
Fibroblasts | 8 | 2016 | 4161 | 0.230 |
Why?
|
Cell Physiological Phenomena | 1 | 2005 | 154 | 0.230 |
Why?
|
Airway Obstruction | 4 | 2012 | 664 | 0.230 |
Why?
|
Immunity, Innate | 9 | 2019 | 2958 | 0.230 |
Why?
|
Chromosomes, Human, Pair 5 | 2 | 2004 | 403 | 0.230 |
Why?
|
Communicable Diseases | 2 | 2022 | 880 | 0.230 |
Why?
|
Shoulder Dislocation | 1 | 2004 | 122 | 0.230 |
Why?
|
Diabetes, Gestational | 2 | 2023 | 1184 | 0.220 |
Why?
|
Metagenome | 3 | 2022 | 418 | 0.220 |
Why?
|
Wood | 2 | 2014 | 89 | 0.220 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2009 | 780 | 0.220 |
Why?
|
Magnesium | 2 | 2018 | 813 | 0.220 |
Why?
|
Repression, Psychology | 1 | 2003 | 44 | 0.220 |
Why?
|
Adjustment Disorders | 1 | 2003 | 70 | 0.220 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2005 | 214 | 0.220 |
Why?
|
Myostatin | 1 | 2023 | 124 | 0.220 |
Why?
|
Bronchopulmonary Dysplasia | 2 | 2016 | 306 | 0.220 |
Why?
|
Ecosystem | 2 | 2017 | 474 | 0.220 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2014 | 2026 | 0.220 |
Why?
|
Puerto Rico | 7 | 2021 | 356 | 0.210 |
Why?
|
Bronchitis | 4 | 1998 | 201 | 0.210 |
Why?
|
Lipids | 6 | 2020 | 3305 | 0.210 |
Why?
|
Brain Ischemia | 2 | 2019 | 3265 | 0.210 |
Why?
|
Anger | 3 | 2006 | 402 | 0.210 |
Why?
|
Risk Assessment | 16 | 2019 | 23338 | 0.210 |
Why?
|
Sympathetic Nervous System | 3 | 1996 | 514 | 0.210 |
Why?
|
Patients | 1 | 2009 | 900 | 0.210 |
Why?
|
Disease Progression | 16 | 2019 | 13284 | 0.210 |
Why?
|
Benchmarking | 3 | 2023 | 1042 | 0.210 |
Why?
|
Time Factors | 36 | 2015 | 40075 | 0.210 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 2002 | 133 | 0.210 |
Why?
|
Pattern Recognition, Automated | 1 | 2008 | 1005 | 0.210 |
Why?
|
Patient Satisfaction | 4 | 2009 | 3396 | 0.210 |
Why?
|
Immunotherapy | 1 | 2017 | 4445 | 0.210 |
Why?
|
Bacterial Toxins | 2 | 1998 | 931 | 0.210 |
Why?
|
Rhinitis, Allergic, Perennial | 1 | 2002 | 57 | 0.210 |
Why?
|
Lymphocytes | 4 | 2019 | 2617 | 0.210 |
Why?
|
Immunoglobulin Joining Region | 1 | 2001 | 36 | 0.200 |
Why?
|
Interleukin-12 | 1 | 2004 | 579 | 0.200 |
Why?
|
Tenascin | 1 | 2022 | 59 | 0.200 |
Why?
|
Parents | 8 | 2010 | 3407 | 0.200 |
Why?
|
Mucin-1 | 2 | 2023 | 543 | 0.200 |
Why?
|
Heat-Shock Proteins | 3 | 2009 | 822 | 0.200 |
Why?
|
Immunoglobulin Constant Regions | 1 | 2001 | 59 | 0.200 |
Why?
|
Insect Proteins | 3 | 2006 | 258 | 0.200 |
Why?
|
Vitamin E | 5 | 2008 | 869 | 0.200 |
Why?
|
Transforming Growth Factor beta | 4 | 2017 | 2007 | 0.200 |
Why?
|
Cell Shape | 2 | 2015 | 375 | 0.200 |
Why?
|
Rural Health | 2 | 2001 | 305 | 0.200 |
Why?
|
Uric Acid | 4 | 2006 | 766 | 0.200 |
Why?
|
Pregnancy Tests | 1 | 2001 | 30 | 0.200 |
Why?
|
Prognosis | 26 | 2023 | 29063 | 0.200 |
Why?
|
RNA | 4 | 2021 | 2749 | 0.200 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2011 | 3508 | 0.200 |
Why?
|
Respiratory Mucosa | 2 | 2016 | 427 | 0.200 |
Why?
|
Database Management Systems | 1 | 2003 | 270 | 0.200 |
Why?
|
DNA-Binding Proteins | 10 | 2020 | 9648 | 0.200 |
Why?
|
Diabetes Mellitus, Type 2 | 7 | 2023 | 11725 | 0.200 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 2001 | 87 | 0.200 |
Why?
|
Bronchial Spasm | 4 | 1990 | 73 | 0.200 |
Why?
|
Phylogeny | 6 | 2021 | 2803 | 0.200 |
Why?
|
DNA | 5 | 2021 | 7301 | 0.200 |
Why?
|
Immune System | 3 | 2017 | 805 | 0.200 |
Why?
|
Compressive Strength | 1 | 2022 | 169 | 0.190 |
Why?
|
HLA-A2 Antigen | 1 | 2021 | 213 | 0.190 |
Why?
|
Chorioamnionitis | 2 | 2020 | 155 | 0.190 |
Why?
|
Geography | 1 | 2003 | 669 | 0.190 |
Why?
|
Myocytes, Smooth Muscle | 3 | 2017 | 687 | 0.190 |
Why?
|
Biological Therapy | 1 | 2022 | 138 | 0.190 |
Why?
|
STAT3 Transcription Factor | 1 | 2005 | 873 | 0.190 |
Why?
|
Genes | 4 | 1999 | 1893 | 0.190 |
Why?
|
CD4-Positive T-Lymphocytes | 8 | 2019 | 4386 | 0.190 |
Why?
|
Rhinitis | 3 | 2002 | 691 | 0.190 |
Why?
|
Maternal Behavior | 2 | 2012 | 311 | 0.190 |
Why?
|
Hemolysin Proteins | 2 | 1998 | 113 | 0.190 |
Why?
|
DNA, Mitochondrial | 2 | 2003 | 817 | 0.190 |
Why?
|
Oligonucleotides | 2 | 2021 | 572 | 0.190 |
Why?
|
Alkanesulfonic Acids | 1 | 2023 | 180 | 0.190 |
Why?
|
Adipose Tissue | 8 | 2016 | 3279 | 0.190 |
Why?
|
Fucosyltransferases | 1 | 2020 | 119 | 0.190 |
Why?
|
Dose-Response Relationship, Drug | 18 | 2018 | 10943 | 0.180 |
Why?
|
Maternal Age | 4 | 2020 | 802 | 0.180 |
Why?
|
Common Cold | 2 | 2018 | 61 | 0.180 |
Why?
|
Middle Cerebral Artery | 1 | 2021 | 264 | 0.180 |
Why?
|
Carrier Proteins | 7 | 2019 | 5021 | 0.180 |
Why?
|
Mice, Inbred BALB C | 8 | 2018 | 6386 | 0.180 |
Why?
|
Emergency Service, Hospital | 10 | 2014 | 7659 | 0.180 |
Why?
|
Medically Underserved Area | 1 | 2022 | 253 | 0.180 |
Why?
|
Urban Population | 9 | 2009 | 2021 | 0.180 |
Why?
|
Body Height | 13 | 2013 | 1577 | 0.180 |
Why?
|
Matrix Metalloproteinase 12 | 2 | 2010 | 49 | 0.180 |
Why?
|
Nitrogen Dioxide | 3 | 2019 | 490 | 0.180 |
Why?
|
Transforming Growth Factor beta1 | 5 | 2015 | 644 | 0.180 |
Why?
|
Abortion, Legal | 1 | 2001 | 116 | 0.180 |
Why?
|
Metacarpophalangeal Joint | 1 | 2000 | 82 | 0.180 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2022 | 177 | 0.180 |
Why?
|
Chromatography, Liquid | 5 | 2023 | 976 | 0.180 |
Why?
|
Intracellular Signaling Peptides and Proteins | 6 | 2020 | 2915 | 0.180 |
Why?
|
Tumor Necrosis Factor-alpha | 7 | 2008 | 4420 | 0.180 |
Why?
|
Splints | 1 | 2000 | 111 | 0.180 |
Why?
|
Population Surveillance | 8 | 2020 | 2616 | 0.180 |
Why?
|
Antioxidants | 5 | 2006 | 1663 | 0.180 |
Why?
|
Disease Management | 5 | 2020 | 2459 | 0.180 |
Why?
|
Genetic Diseases, Inborn | 3 | 2013 | 587 | 0.180 |
Why?
|
Enhancer Elements, Genetic | 3 | 2017 | 1341 | 0.180 |
Why?
|
Cats | 8 | 2003 | 998 | 0.170 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 6 | 2018 | 3255 | 0.170 |
Why?
|
Calcitriol | 2 | 2012 | 298 | 0.170 |
Why?
|
Transcription Factors | 10 | 2016 | 12208 | 0.170 |
Why?
|
Glycine Hydroxymethyltransferase | 2 | 2012 | 32 | 0.170 |
Why?
|
Hypertension | 14 | 2006 | 8480 | 0.170 |
Why?
|
Paraproteinemias | 1 | 2022 | 246 | 0.170 |
Why?
|
Mesenchymal Stem Cells | 1 | 2010 | 1632 | 0.170 |
Why?
|
Muscle Contraction | 1 | 2004 | 1240 | 0.170 |
Why?
|
Haemophilus influenzae | 1 | 2019 | 171 | 0.170 |
Why?
|
beta-Globins | 1 | 2019 | 113 | 0.170 |
Why?
|
Ethanolamines | 1 | 2019 | 158 | 0.170 |
Why?
|
Cockroaches | 9 | 2006 | 96 | 0.170 |
Why?
|
Chorionic Gonadotropin | 1 | 2001 | 477 | 0.170 |
Why?
|
Physicians, Family | 3 | 2009 | 345 | 0.170 |
Why?
|
Lysine | 1 | 2024 | 1007 | 0.170 |
Why?
|
Signal Transduction | 13 | 2024 | 23403 | 0.170 |
Why?
|
Carbon Dioxide | 2 | 2023 | 1150 | 0.170 |
Why?
|
Placebo Effect | 2 | 2020 | 502 | 0.170 |
Why?
|
Nasal Mucosa | 2 | 2020 | 373 | 0.170 |
Why?
|
Immunization | 2 | 2017 | 1256 | 0.170 |
Why?
|
Hemolysis | 1 | 2021 | 420 | 0.170 |
Why?
|
Metals, Heavy | 1 | 2020 | 139 | 0.170 |
Why?
|
Histocompatibility Antigens Class II | 4 | 2003 | 1475 | 0.170 |
Why?
|
Austria | 3 | 2015 | 203 | 0.170 |
Why?
|
Type A Personality | 1 | 1998 | 25 | 0.170 |
Why?
|
Fibroblast Growth Factors | 2 | 2023 | 879 | 0.170 |
Why?
|
Statistics as Topic | 5 | 2016 | 2373 | 0.170 |
Why?
|
Cell Movement | 4 | 2021 | 5217 | 0.170 |
Why?
|
Carbon Monoxide | 3 | 2019 | 531 | 0.160 |
Why?
|
Multicenter Studies as Topic | 7 | 2017 | 1677 | 0.160 |
Why?
|
Chromosomes, Human, Pair 18 | 2 | 2018 | 245 | 0.160 |
Why?
|
3' Untranslated Regions | 4 | 2014 | 513 | 0.160 |
Why?
|
Intention to Treat Analysis | 1 | 2020 | 426 | 0.160 |
Why?
|
Age Distribution | 12 | 2009 | 2902 | 0.160 |
Why?
|
Hydrocortisone | 5 | 2015 | 1826 | 0.160 |
Why?
|
Murine hepatitis virus | 2 | 1995 | 20 | 0.160 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2013 | 4751 | 0.160 |
Why?
|
Homocysteine | 2 | 2012 | 647 | 0.160 |
Why?
|
Health Education | 3 | 1995 | 1056 | 0.160 |
Why?
|
Body Composition | 6 | 1997 | 2401 | 0.160 |
Why?
|
Hand Strength | 2 | 2000 | 448 | 0.160 |
Why?
|
Molecular Sequence Data | 11 | 2011 | 18111 | 0.160 |
Why?
|
ABO Blood-Group System | 1 | 2020 | 367 | 0.160 |
Why?
|
Thumb | 1 | 2000 | 227 | 0.160 |
Why?
|
Smad2 Protein | 1 | 2018 | 156 | 0.160 |
Why?
|
Practice Guidelines as Topic | 8 | 2020 | 7279 | 0.160 |
Why?
|
Fracture Healing | 2 | 2011 | 427 | 0.160 |
Why?
|
Epistasis, Genetic | 1 | 2020 | 365 | 0.160 |
Why?
|
Helminths | 1 | 1998 | 35 | 0.160 |
Why?
|
Interleukin-2 | 2 | 2024 | 1904 | 0.160 |
Why?
|
Cerebellar Nuclei | 1 | 2018 | 52 | 0.160 |
Why?
|
Cough | 7 | 2019 | 555 | 0.160 |
Why?
|
Netherlands | 17 | 2016 | 2170 | 0.160 |
Why?
|
Measles | 1 | 2000 | 168 | 0.160 |
Why?
|
Vitamin D-Binding Protein | 2 | 2021 | 129 | 0.160 |
Why?
|
Environmental Pollutants | 2 | 2023 | 1179 | 0.160 |
Why?
|
Depression, Postpartum | 1 | 2022 | 340 | 0.150 |
Why?
|
Immunoassay | 2 | 2020 | 752 | 0.150 |
Why?
|
Histocompatibility Antigens Class I | 3 | 2007 | 1366 | 0.150 |
Why?
|
Body Image | 1 | 2003 | 610 | 0.150 |
Why?
|
Fluorocarbons | 1 | 2023 | 452 | 0.150 |
Why?
|
Statistics, Nonparametric | 2 | 2003 | 2886 | 0.150 |
Why?
|
Sputum | 2 | 2021 | 476 | 0.150 |
Why?
|
Population Density | 3 | 2021 | 196 | 0.150 |
Why?
|
Range of Motion, Articular | 1 | 2004 | 1578 | 0.150 |
Why?
|
Pulmonary Alveoli | 3 | 2010 | 675 | 0.150 |
Why?
|
Problem Solving | 1 | 2020 | 440 | 0.150 |
Why?
|
Women | 1 | 1999 | 230 | 0.150 |
Why?
|
Fossil Fuels | 1 | 1997 | 44 | 0.150 |
Why?
|
Species Specificity | 3 | 2017 | 2478 | 0.150 |
Why?
|
Antigen Presentation | 3 | 1998 | 1284 | 0.150 |
Why?
|
Tryptophan | 1 | 2019 | 478 | 0.150 |
Why?
|
Sphingosine | 1 | 2019 | 307 | 0.150 |
Why?
|
Peptide Fragments | 1 | 2010 | 5097 | 0.150 |
Why?
|
Microbial Interactions | 1 | 2017 | 76 | 0.150 |
Why?
|
Triclosan | 1 | 2017 | 55 | 0.150 |
Why?
|
Air Pollution | 4 | 2023 | 2286 | 0.150 |
Why?
|
Mice, Inbred C57BL | 11 | 2021 | 21827 | 0.150 |
Why?
|
Calcitonin | 2 | 2008 | 336 | 0.150 |
Why?
|
Information Storage and Retrieval | 1 | 2003 | 824 | 0.150 |
Why?
|
Lysophospholipids | 1 | 2019 | 331 | 0.150 |
Why?
|
Bone and Bones | 9 | 2003 | 2575 | 0.150 |
Why?
|
Cholesterol, HDL | 5 | 2018 | 1814 | 0.150 |
Why?
|
Internationality | 1 | 2022 | 1003 | 0.150 |
Why?
|
Genome, Viral | 1 | 2021 | 667 | 0.150 |
Why?
|
Cysteine Endopeptidases | 4 | 2015 | 563 | 0.150 |
Why?
|
Proportional Hazards Models | 10 | 2019 | 12354 | 0.150 |
Why?
|
Parabens | 1 | 2017 | 108 | 0.140 |
Why?
|
Arabs | 1 | 1999 | 178 | 0.140 |
Why?
|
Heroin Dependence | 1 | 2017 | 175 | 0.140 |
Why?
|
Protein Precursors | 3 | 2008 | 1154 | 0.140 |
Why?
|
Smoke | 2 | 2023 | 227 | 0.140 |
Why?
|
International Normalized Ratio | 1 | 2018 | 367 | 0.140 |
Why?
|
Globus Pallidus | 1 | 2018 | 253 | 0.140 |
Why?
|
Epidemiologic Methods | 6 | 2001 | 1364 | 0.140 |
Why?
|
Receptors, Immunologic | 3 | 2022 | 1423 | 0.140 |
Why?
|
Genes, MHC Class I | 1 | 1997 | 258 | 0.140 |
Why?
|
Sex Distribution | 9 | 2003 | 2297 | 0.140 |
Why?
|
Listeria monocytogenes | 1 | 1998 | 250 | 0.140 |
Why?
|
Cell Differentiation | 7 | 2010 | 11483 | 0.140 |
Why?
|
Mites | 6 | 2002 | 43 | 0.140 |
Why?
|
Glycolysis | 1 | 2020 | 827 | 0.140 |
Why?
|
Databases, Factual | 5 | 2024 | 7729 | 0.140 |
Why?
|
Primary Prevention | 2 | 2014 | 1167 | 0.140 |
Why?
|
Drosophila Proteins | 2 | 2002 | 1703 | 0.140 |
Why?
|
Age of Onset | 8 | 2015 | 3271 | 0.140 |
Why?
|
Child Day Care Centers | 3 | 2002 | 123 | 0.140 |
Why?
|
HLA Antigens | 3 | 2018 | 1381 | 0.140 |
Why?
|
Herpes Zoster | 1 | 2018 | 264 | 0.140 |
Why?
|
Pneumococcal Infections | 1 | 2020 | 497 | 0.140 |
Why?
|
Housing | 4 | 2005 | 664 | 0.140 |
Why?
|
Leukotrienes | 4 | 2018 | 255 | 0.140 |
Why?
|
Socioeconomic Factors | 14 | 2012 | 7785 | 0.130 |
Why?
|
Social Environment | 4 | 1994 | 1023 | 0.130 |
Why?
|
Down-Regulation | 5 | 2020 | 3002 | 0.130 |
Why?
|
Chronic Disease | 11 | 2016 | 9146 | 0.130 |
Why?
|
Delivery of Health Care | 7 | 2020 | 5319 | 0.130 |
Why?
|
Home Care Services, Hospital-Based | 1 | 2015 | 44 | 0.130 |
Why?
|
Serpin E2 | 3 | 2011 | 48 | 0.130 |
Why?
|
B-Lymphocytes | 3 | 2015 | 4665 | 0.130 |
Why?
|
Androgens | 1 | 2023 | 1281 | 0.130 |
Why?
|
Analgesics, Non-Narcotic | 2 | 2014 | 365 | 0.130 |
Why?
|
Utilization Review | 2 | 2015 | 392 | 0.130 |
Why?
|
Glutathione Transferase | 2 | 2010 | 595 | 0.130 |
Why?
|
Proprotein Convertase 1 | 1 | 2015 | 10 | 0.130 |
Why?
|
Resuscitation | 1 | 2000 | 658 | 0.130 |
Why?
|
Hypertrophy | 2 | 2010 | 569 | 0.130 |
Why?
|
Occupational Diseases | 8 | 2006 | 1471 | 0.130 |
Why?
|
alpha Catenin | 1 | 2015 | 38 | 0.130 |
Why?
|
Dermatophagoides farinae | 1 | 2015 | 25 | 0.130 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2021 | 2073 | 0.130 |
Why?
|
Serine Proteinase Inhibitors | 2 | 2011 | 179 | 0.130 |
Why?
|
Molecular Targeted Therapy | 2 | 2020 | 2727 | 0.130 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2009 | 2988 | 0.130 |
Why?
|
Ankyrin Repeat | 1 | 2015 | 17 | 0.130 |
Why?
|
Cohort Effect | 1 | 1995 | 39 | 0.130 |
Why?
|
Evolution, Molecular | 2 | 2003 | 1940 | 0.130 |
Why?
|
Overweight | 3 | 2018 | 2371 | 0.130 |
Why?
|
Chemokines | 2 | 2020 | 970 | 0.130 |
Why?
|
Cells, Cultured | 14 | 2018 | 19229 | 0.130 |
Why?
|
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 1 | 2015 | 52 | 0.130 |
Why?
|
Chromosomes, Human, Pair 2 | 2 | 2015 | 326 | 0.130 |
Why?
|
Mucus | 2 | 2019 | 321 | 0.130 |
Why?
|
Folic Acid Deficiency | 1 | 2016 | 115 | 0.130 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2018 | 546 | 0.130 |
Why?
|
Anxiety | 4 | 2015 | 4297 | 0.130 |
Why?
|
Office Visits | 4 | 2015 | 598 | 0.130 |
Why?
|
Mice, Inbred DBA | 2 | 2015 | 642 | 0.130 |
Why?
|
Aneurysm | 1 | 2018 | 339 | 0.130 |
Why?
|
Bronchiolitis, Viral | 2 | 2014 | 74 | 0.130 |
Why?
|
Receptors, Adrenergic, beta | 4 | 2006 | 246 | 0.130 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2017 | 362 | 0.130 |
Why?
|
Acetaminophen | 2 | 2014 | 545 | 0.130 |
Why?
|
alpha-N-Acetylgalactosaminidase | 1 | 2014 | 5 | 0.130 |
Why?
|
Semaphorins | 1 | 2015 | 101 | 0.130 |
Why?
|
Mice, 129 Strain | 1 | 2015 | 386 | 0.130 |
Why?
|
Educational Status | 6 | 2023 | 2540 | 0.120 |
Why?
|
Serotonin | 3 | 1998 | 1017 | 0.120 |
Why?
|
International Classification of Diseases | 3 | 2016 | 867 | 0.120 |
Why?
|
Anthropometry | 8 | 2022 | 1350 | 0.120 |
Why?
|
Sensitivity and Specificity | 14 | 2018 | 14722 | 0.120 |
Why?
|
Personality Development | 2 | 1992 | 245 | 0.120 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1998 | 1369 | 0.120 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2020 | 736 | 0.120 |
Why?
|
Stress, Psychological | 6 | 2015 | 4245 | 0.120 |
Why?
|
Amides | 1 | 2017 | 459 | 0.120 |
Why?
|
Salmonella Infections, Animal | 1 | 2014 | 65 | 0.120 |
Why?
|
Drug Therapy | 2 | 2008 | 497 | 0.120 |
Why?
|
Fever | 3 | 2008 | 1616 | 0.120 |
Why?
|
Antibiosis | 1 | 2014 | 45 | 0.120 |
Why?
|
Proteomics | 2 | 2023 | 3638 | 0.120 |
Why?
|
Pacifiers | 1 | 2013 | 11 | 0.120 |
Why?
|
Nutritional Status | 3 | 2023 | 1609 | 0.120 |
Why?
|
Mitochondria | 1 | 2007 | 3520 | 0.120 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2015 | 175 | 0.120 |
Why?
|
Peak Expiratory Flow Rate | 6 | 2004 | 141 | 0.120 |
Why?
|
Chemokine CXCL5 | 1 | 2013 | 27 | 0.120 |
Why?
|
Smoking Cessation | 3 | 2017 | 2071 | 0.120 |
Why?
|
Shock, Septic | 1 | 2021 | 775 | 0.120 |
Why?
|
Hospitalization | 12 | 2022 | 10262 | 0.120 |
Why?
|
Fatty Acid Desaturases | 1 | 2014 | 102 | 0.120 |
Why?
|
Exons | 7 | 2018 | 2437 | 0.120 |
Why?
|
Sulfides | 3 | 2012 | 165 | 0.120 |
Why?
|
Orthopedic Procedures | 1 | 2004 | 1288 | 0.120 |
Why?
|
beta 2-Microglobulin | 1 | 1995 | 315 | 0.120 |
Why?
|
Europe | 4 | 2022 | 3339 | 0.120 |
Why?
|
Epinephrine | 3 | 1994 | 792 | 0.120 |
Why?
|
Critical Illness | 3 | 2022 | 2670 | 0.120 |
Why?
|
Biological Evolution | 1 | 2000 | 1076 | 0.120 |
Why?
|
Copper | 3 | 2005 | 366 | 0.120 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 1997 | 560 | 0.120 |
Why?
|
Chemokine CXCL2 | 1 | 2013 | 111 | 0.120 |
Why?
|
Oligonucleotide Array Sequence Analysis | 6 | 2016 | 3920 | 0.120 |
Why?
|
Drug Administration Schedule | 8 | 2007 | 4933 | 0.120 |
Why?
|
Chemokine CXCL1 | 1 | 2013 | 101 | 0.120 |
Why?
|
Cholesterol, LDL | 9 | 2018 | 2356 | 0.120 |
Why?
|
Aspergillus niger | 1 | 2013 | 17 | 0.120 |
Why?
|
Alternative Splicing | 4 | 2016 | 1117 | 0.120 |
Why?
|
Normal Distribution | 1 | 2014 | 280 | 0.120 |
Why?
|
T-Lymphocytes | 8 | 2020 | 10180 | 0.110 |
Why?
|
Hematopoiesis | 1 | 2023 | 2072 | 0.110 |
Why?
|
Neuropeptides | 1 | 2019 | 942 | 0.110 |
Why?
|
Calcium | 4 | 2018 | 5756 | 0.110 |
Why?
|
Body Weights and Measures | 1 | 2014 | 211 | 0.110 |
Why?
|
Gene Dosage | 2 | 2008 | 1252 | 0.110 |
Why?
|
Retrospective Studies | 24 | 2021 | 77449 | 0.110 |
Why?
|
Forecasting | 4 | 2015 | 2951 | 0.110 |
Why?
|
Cyclopropanes | 3 | 2012 | 416 | 0.110 |
Why?
|
Hypolipidemic Agents | 1 | 2018 | 604 | 0.110 |
Why?
|
Leishmania major | 1 | 2013 | 57 | 0.110 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2018 | 602 | 0.110 |
Why?
|
Ultrasonography, Prenatal | 1 | 2001 | 1695 | 0.110 |
Why?
|
Chromosomes, Human, Pair 19 | 2 | 2012 | 367 | 0.110 |
Why?
|
Environment | 5 | 2016 | 1124 | 0.110 |
Why?
|
Data Collection | 5 | 2023 | 3341 | 0.110 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 3 | 2015 | 437 | 0.110 |
Why?
|
Calcifediol | 3 | 2023 | 166 | 0.110 |
Why?
|
Prednisolone | 1 | 2014 | 334 | 0.110 |
Why?
|
Ibuprofen | 1 | 2014 | 236 | 0.110 |
Why?
|
Confidence Intervals | 9 | 2017 | 2971 | 0.110 |
Why?
|
Biometry | 3 | 2007 | 558 | 0.110 |
Why?
|
Weaning | 1 | 2013 | 105 | 0.110 |
Why?
|
Leukotriene E4 | 2 | 2012 | 79 | 0.110 |
Why?
|
gamma-Glutamyl Hydrolase | 1 | 2012 | 9 | 0.110 |
Why?
|
Intensive Care Units, Pediatric | 2 | 2020 | 981 | 0.110 |
Why?
|
Thiophenes | 1 | 2017 | 588 | 0.110 |
Why?
|
Catecholamines | 1 | 1993 | 387 | 0.110 |
Why?
|
Porphobilinogen Synthase | 2 | 2003 | 27 | 0.110 |
Why?
|
Hyperlipidemias | 2 | 2013 | 789 | 0.110 |
Why?
|
Pulmonary Aspergillosis | 1 | 2013 | 47 | 0.110 |
Why?
|
Interferon-alpha | 1 | 2017 | 895 | 0.110 |
Why?
|
Systems Integration | 1 | 2014 | 440 | 0.110 |
Why?
|
Phobic Disorders | 1 | 1995 | 439 | 0.110 |
Why?
|
Mice, Knockout | 8 | 2021 | 14557 | 0.110 |
Why?
|
Diabetes Mellitus | 3 | 2022 | 5751 | 0.110 |
Why?
|
Maternal-Fetal Exchange | 3 | 2018 | 456 | 0.110 |
Why?
|
Liver | 5 | 2021 | 7474 | 0.110 |
Why?
|
Rural Population | 9 | 2002 | 2210 | 0.110 |
Why?
|
Mice, Inbred NOD | 2 | 2015 | 1878 | 0.110 |
Why?
|
Administration, Oral | 6 | 2013 | 3913 | 0.110 |
Why?
|
Osteoarthritis | 1 | 2000 | 1036 | 0.110 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 3 | 2012 | 284 | 0.110 |
Why?
|
HLA-DQ Antigens | 1 | 2012 | 210 | 0.110 |
Why?
|
Arthrogryposis | 1 | 2013 | 72 | 0.110 |
Why?
|
Cesarean Section | 3 | 2022 | 1365 | 0.110 |
Why?
|
Pharmaceutical Preparations | 3 | 2012 | 1071 | 0.100 |
Why?
|
Immobilization | 1 | 1993 | 236 | 0.100 |
Why?
|
Cadherins | 1 | 2017 | 907 | 0.100 |
Why?
|
Quality of Life | 7 | 2012 | 12804 | 0.100 |
Why?
|
Heterozygote | 3 | 2021 | 2804 | 0.100 |
Why?
|
Iron | 3 | 2019 | 1774 | 0.100 |
Why?
|
Bony Callus | 1 | 2011 | 36 | 0.100 |
Why?
|
Bronchial Diseases | 3 | 1987 | 151 | 0.100 |
Why?
|
Physical Stimulation | 1 | 2013 | 525 | 0.100 |
Why?
|
Fetal Proteins | 1 | 2012 | 94 | 0.100 |
Why?
|
Fathers | 3 | 2005 | 358 | 0.100 |
Why?
|
Heart Rate | 3 | 2005 | 4091 | 0.100 |
Why?
|
Intubation, Intratracheal | 1 | 2000 | 1364 | 0.100 |
Why?
|
Leishmaniasis, Cutaneous | 1 | 2013 | 124 | 0.100 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2017 | 1375 | 0.100 |
Why?
|
Mass Spectrometry | 4 | 2022 | 2203 | 0.100 |
Why?
|
Cytochromes b | 1 | 2011 | 36 | 0.100 |
Why?
|
Anticarcinogenic Agents | 1 | 2013 | 253 | 0.100 |
Why?
|
Solubility | 2 | 2008 | 1085 | 0.100 |
Why?
|
Energy Metabolism | 2 | 2020 | 2899 | 0.100 |
Why?
|
Norepinephrine | 5 | 1996 | 909 | 0.100 |
Why?
|
Respiratory Syncytial Virus, Human | 1 | 2014 | 139 | 0.100 |
Why?
|
Calcification, Physiologic | 1 | 2012 | 169 | 0.100 |
Why?
|
Patient Compliance | 4 | 2010 | 2684 | 0.100 |
Why?
|
Biomarkers, Pharmacological | 1 | 2012 | 162 | 0.100 |
Why?
|
Cold Temperature | 8 | 1989 | 772 | 0.100 |
Why?
|
18-Hydroxycorticosterone | 1 | 1991 | 3 | 0.100 |
Why?
|
Obstetric Labor, Premature | 1 | 1993 | 279 | 0.100 |
Why?
|
STAT6 Transcription Factor | 1 | 2011 | 199 | 0.100 |
Why?
|
Fishes | 1 | 1994 | 569 | 0.100 |
Why?
|
Pulmonary Eosinophilia | 1 | 2012 | 82 | 0.100 |
Why?
|
Zinc Fingers | 1 | 2013 | 585 | 0.100 |
Why?
|
Social Support | 3 | 2013 | 2118 | 0.100 |
Why?
|
Influenza, Human | 1 | 2022 | 1479 | 0.100 |
Why?
|
Leukopenia | 1 | 1991 | 212 | 0.100 |
Why?
|
Classification | 1 | 2011 | 129 | 0.100 |
Why?
|
Imaging, Three-Dimensional | 5 | 2021 | 4042 | 0.100 |
Why?
|
Pulmonary Emphysema | 2 | 2015 | 672 | 0.100 |
Why?
|
Tandem Repeat Sequences | 2 | 2002 | 185 | 0.100 |
Why?
|
Lymphoma | 1 | 2020 | 1877 | 0.100 |
Why?
|
Kallikreins | 1 | 2012 | 258 | 0.100 |
Why?
|
Bariatric Surgery | 1 | 2021 | 952 | 0.100 |
Why?
|
Allylamine | 2 | 2001 | 10 | 0.100 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 2 | 2009 | 310 | 0.100 |
Why?
|
Attitude | 3 | 1992 | 776 | 0.100 |
Why?
|
Alcohol Amnestic Disorder | 1 | 1990 | 26 | 0.100 |
Why?
|
Hyperglycemia | 1 | 2000 | 1373 | 0.100 |
Why?
|
Inflammation Mediators | 2 | 2017 | 1889 | 0.100 |
Why?
|
Obesity, Morbid | 1 | 2021 | 1213 | 0.100 |
Why?
|
Immunomodulation | 1 | 2015 | 541 | 0.090 |
Why?
|
Posture | 2 | 1986 | 958 | 0.090 |
Why?
|
Perinatal Care | 1 | 2013 | 227 | 0.090 |
Why?
|
Primary Health Care | 3 | 2022 | 4558 | 0.090 |
Why?
|
Ambulatory Care | 2 | 2001 | 2708 | 0.090 |
Why?
|
Alcian Blue | 1 | 2010 | 13 | 0.090 |
Why?
|
Cell Nucleus | 3 | 2015 | 2969 | 0.090 |
Why?
|
Referral and Consultation | 2 | 2016 | 3528 | 0.090 |
Why?
|
Biodiversity | 3 | 2018 | 341 | 0.090 |
Why?
|
Electrocardiography | 7 | 2010 | 6442 | 0.090 |
Why?
|
Collagen Type X | 1 | 2010 | 16 | 0.090 |
Why?
|
Likelihood Functions | 4 | 2016 | 1005 | 0.090 |
Why?
|
alpha-2-Antiplasmin | 1 | 2010 | 13 | 0.090 |
Why?
|
Sequence Analysis, DNA | 4 | 2017 | 4803 | 0.090 |
Why?
|
Fibroblast Growth Factor 1 | 1 | 2010 | 54 | 0.090 |
Why?
|
Leukocytosis | 1 | 1991 | 247 | 0.090 |
Why?
|
Lung Volume Measurements | 6 | 1997 | 378 | 0.090 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 1992 | 214 | 0.090 |
Why?
|
Glycoproteins | 8 | 2008 | 2263 | 0.090 |
Why?
|
Pregnancy Trimester, Second | 3 | 2021 | 732 | 0.090 |
Why?
|
Fluorescence | 2 | 2005 | 751 | 0.090 |
Why?
|
Diagnostic Imaging | 1 | 2005 | 3507 | 0.090 |
Why?
|
Amyloid beta-Protein Precursor | 2 | 2006 | 1121 | 0.090 |
Why?
|
Intestines | 2 | 2016 | 1924 | 0.090 |
Why?
|
Patella | 4 | 2007 | 320 | 0.090 |
Why?
|
DNA Mutational Analysis | 6 | 2021 | 4186 | 0.090 |
Why?
|
Immunoenzyme Techniques | 1 | 2013 | 1799 | 0.090 |
Why?
|
Receptors, Serotonin, 5-HT4 | 1 | 2010 | 16 | 0.090 |
Why?
|
Plants, Toxic | 2 | 1996 | 76 | 0.090 |
Why?
|
Radionuclide Imaging | 2 | 1999 | 2031 | 0.090 |
Why?
|
North America | 4 | 2021 | 1249 | 0.090 |
Why?
|
Dogs | 5 | 2020 | 3912 | 0.090 |
Why?
|
Methylprednisolone | 2 | 2008 | 387 | 0.090 |
Why?
|
Alkaline Phosphatase | 3 | 2010 | 865 | 0.090 |
Why?
|
Immunoglobulin Light Chains | 1 | 1991 | 277 | 0.090 |
Why?
|
Interleukin-8 | 2 | 2023 | 690 | 0.090 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2010 | 103 | 0.090 |
Why?
|
Family Nursing | 1 | 2009 | 20 | 0.090 |
Why?
|
Bacterial Infections | 2 | 2008 | 1401 | 0.090 |
Why?
|
Hypoglycemic Agents | 3 | 2017 | 2872 | 0.090 |
Why?
|
Genes, MHC Class II | 1 | 1991 | 457 | 0.090 |
Why?
|
Birth Weight | 5 | 2012 | 2069 | 0.090 |
Why?
|
Warfarin | 1 | 2018 | 1496 | 0.090 |
Why?
|
Stem Cells | 2 | 2000 | 3567 | 0.090 |
Why?
|
Egg Proteins | 1 | 2009 | 58 | 0.090 |
Why?
|
Theophylline | 2 | 2008 | 132 | 0.090 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3133 | 0.090 |
Why?
|
Collagen Type II | 1 | 2010 | 151 | 0.090 |
Why?
|
Nicotine | 1 | 2014 | 681 | 0.090 |
Why?
|
Alendronate | 2 | 2001 | 171 | 0.090 |
Why?
|
Hypercholesterolemia | 4 | 2001 | 1151 | 0.090 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2010 | 197 | 0.090 |
Why?
|
Cost Savings | 1 | 2015 | 926 | 0.090 |
Why?
|
Ionomycin | 1 | 2009 | 109 | 0.090 |
Why?
|
Serum Albumin | 1 | 1992 | 676 | 0.090 |
Why?
|
Epilepsy | 2 | 2022 | 3310 | 0.090 |
Why?
|
Cell Proliferation | 9 | 2017 | 10481 | 0.090 |
Why?
|
Systole | 4 | 2003 | 958 | 0.090 |
Why?
|
Drug Design | 2 | 2005 | 1076 | 0.090 |
Why?
|
Angiography, Digital Subtraction | 2 | 2021 | 341 | 0.090 |
Why?
|
Health Maintenance Organizations | 3 | 2001 | 642 | 0.090 |
Why?
|
Molecular Sequence Annotation | 1 | 2012 | 528 | 0.090 |
Why?
|
Fasting | 5 | 1998 | 1593 | 0.090 |
Why?
|
Congresses as Topic | 1 | 2014 | 764 | 0.090 |
Why?
|
Protein Kinase C-alpha | 1 | 2009 | 112 | 0.080 |
Why?
|
Thrombospondins | 1 | 2010 | 197 | 0.080 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2011 | 345 | 0.080 |
Why?
|
Medical Informatics | 1 | 2016 | 745 | 0.080 |
Why?
|
Comorbidity | 9 | 2017 | 10388 | 0.080 |
Why?
|
G-Protein-Coupled Receptor Kinase 5 | 1 | 2008 | 5 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2016 | 3597 | 0.080 |
Why?
|
Psychotropic Drugs | 1 | 1995 | 894 | 0.080 |
Why?
|
Chromosomes, Human, Pair 9 | 2 | 2009 | 535 | 0.080 |
Why?
|
Leukocytes | 2 | 2017 | 2043 | 0.080 |
Why?
|
Medication Therapy Management | 1 | 2010 | 127 | 0.080 |
Why?
|
Chromosomes, Human, Pair 1 | 3 | 2004 | 658 | 0.080 |
Why?
|
Azathioprine | 1 | 2010 | 353 | 0.080 |
Why?
|
Triglycerides | 7 | 2000 | 2454 | 0.080 |
Why?
|
Intermediate Filament Proteins | 2 | 2007 | 269 | 0.080 |
Why?
|
Heart Diseases | 2 | 2009 | 2788 | 0.080 |
Why?
|
Phagocytosis | 1 | 2014 | 1539 | 0.080 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2023 | 2425 | 0.080 |
Why?
|
Sphingomyelins | 2 | 2023 | 105 | 0.080 |
Why?
|
Mice, SCID | 3 | 2010 | 2716 | 0.080 |
Why?
|
Meta-Analysis as Topic | 2 | 2012 | 1344 | 0.080 |
Why?
|
Receptor, Parathyroid Hormone, Type 1 | 1 | 2010 | 307 | 0.080 |
Why?
|
Bone Density | 5 | 2012 | 3468 | 0.080 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2022 | 2208 | 0.080 |
Why?
|
Creatinine | 6 | 2003 | 1919 | 0.080 |
Why?
|
Chemokine CCL11 | 2 | 2006 | 129 | 0.080 |
Why?
|
Clinical Laboratory Techniques | 1 | 1994 | 738 | 0.080 |
Why?
|
Introns | 4 | 2009 | 991 | 0.080 |
Why?
|
Poly C | 1 | 2007 | 7 | 0.080 |
Why?
|
Drug Utilization | 4 | 2005 | 1183 | 0.080 |
Why?
|
Canada | 4 | 2012 | 2065 | 0.080 |
Why?
|
Immunologic Factors | 1 | 2017 | 1580 | 0.080 |
Why?
|
Deafness | 3 | 1998 | 458 | 0.080 |
Why?
|
Alcoholic Intoxication | 2 | 1990 | 188 | 0.080 |
Why?
|
Receptors, Leukotriene | 1 | 2009 | 123 | 0.080 |
Why?
|
Biomedical Research | 1 | 2004 | 3309 | 0.080 |
Why?
|
Genetic Techniques | 2 | 2008 | 435 | 0.080 |
Why?
|
Arachidonate 5-Lipoxygenase | 2 | 2006 | 144 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 1998 | 4479 | 0.080 |
Why?
|
Rats | 11 | 2012 | 24260 | 0.080 |
Why?
|
Indians, Central American | 1 | 2007 | 15 | 0.080 |
Why?
|
Ion Channels | 1 | 2013 | 1056 | 0.080 |
Why?
|
Immunoglobulin G | 3 | 2007 | 4560 | 0.080 |
Why?
|
Sampling Studies | 4 | 2003 | 623 | 0.080 |
Why?
|
Verbal Learning | 1 | 1990 | 467 | 0.080 |
Why?
|
Gene Order | 2 | 2007 | 176 | 0.080 |
Why?
|
Antibodies, Monoclonal | 3 | 2017 | 9274 | 0.080 |
Why?
|
Mechanotransduction, Cellular | 1 | 2013 | 541 | 0.080 |
Why?
|
Tibia | 5 | 2007 | 1077 | 0.080 |
Why?
|
Tibial Fractures | 1 | 2010 | 269 | 0.080 |
Why?
|
House Calls | 1 | 2009 | 160 | 0.080 |
Why?
|
Cromolyn Sodium | 4 | 2001 | 87 | 0.080 |
Why?
|
Coloring Agents | 1 | 2010 | 566 | 0.080 |
Why?
|
Skinfold Thickness | 3 | 2012 | 162 | 0.080 |
Why?
|
Fats | 1 | 2008 | 102 | 0.070 |
Why?
|
Causality | 3 | 2001 | 1275 | 0.070 |
Why?
|
Delayed-Action Preparations | 2 | 2010 | 968 | 0.070 |
Why?
|
Extracellular Matrix Proteins | 1 | 2011 | 849 | 0.070 |
Why?
|
Cell Extracts | 1 | 1987 | 138 | 0.070 |
Why?
|
Drug Prescriptions | 3 | 2008 | 1637 | 0.070 |
Why?
|
Massachusetts | 12 | 2014 | 8663 | 0.070 |
Why?
|
Potassium | 1 | 1991 | 1336 | 0.070 |
Why?
|
Tretinoin | 1 | 2010 | 517 | 0.070 |
Why?
|
Tandem Mass Spectrometry | 2 | 2023 | 1157 | 0.070 |
Why?
|
Culture Media | 1 | 2009 | 908 | 0.070 |
Why?
|
Forced Expiratory Flow Rates | 6 | 2017 | 74 | 0.070 |
Why?
|
Mutagenesis | 2 | 2021 | 1266 | 0.070 |
Why?
|
Sodium | 2 | 1994 | 1623 | 0.070 |
Why?
|
Peptidoglycan | 2 | 2006 | 246 | 0.070 |
Why?
|
Hep G2 Cells | 2 | 2021 | 393 | 0.070 |
Why?
|
Polymerase Chain Reaction | 6 | 2018 | 6171 | 0.070 |
Why?
|
Membrane Potentials | 1 | 2010 | 1137 | 0.070 |
Why?
|
Genetic Privacy | 1 | 2007 | 60 | 0.070 |
Why?
|
Agriculture | 2 | 2012 | 190 | 0.070 |
Why?
|
Brazil | 2 | 2021 | 1270 | 0.070 |
Why?
|
Chi-Square Distribution | 5 | 2004 | 3508 | 0.070 |
Why?
|
Selection Bias | 2 | 2001 | 371 | 0.070 |
Why?
|
Toll-Like Receptor 2 | 2 | 2006 | 354 | 0.070 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 3658 | 0.070 |
Why?
|
Death, Sudden, Cardiac | 1 | 1995 | 1541 | 0.070 |
Why?
|
Social Class | 3 | 2005 | 1999 | 0.070 |
Why?
|
Probability | 5 | 2004 | 2505 | 0.070 |
Why?
|
Femoral Fractures | 1 | 2010 | 376 | 0.070 |
Why?
|
Semantics | 1 | 1990 | 584 | 0.070 |
Why?
|
Germ Cells | 2 | 2021 | 631 | 0.070 |
Why?
|
Codon, Nonsense | 1 | 2007 | 281 | 0.070 |
Why?
|
Mortality | 2 | 1995 | 2864 | 0.070 |
Why?
|
Adult Children | 2 | 2003 | 100 | 0.070 |
Why?
|
NF-kappa B | 3 | 2017 | 2499 | 0.070 |
Why?
|
Demography | 4 | 2017 | 1656 | 0.070 |
Why?
|
Disease Models, Animal | 5 | 2019 | 18029 | 0.070 |
Why?
|
Mutation | 8 | 2023 | 29786 | 0.070 |
Why?
|
Rats, Wistar | 1 | 2010 | 1901 | 0.070 |
Why?
|
Anti-Allergic Agents | 1 | 2007 | 141 | 0.070 |
Why?
|
Family Practice | 1 | 2009 | 516 | 0.070 |
Why?
|
Basophils | 2 | 2021 | 389 | 0.070 |
Why?
|
Mesoderm | 1 | 2009 | 686 | 0.070 |
Why?
|
DNA, Complementary | 2 | 2011 | 2050 | 0.070 |
Why?
|
Adrenergic beta-Antagonists | 2 | 1996 | 1240 | 0.070 |
Why?
|
Amino Acid Substitution | 3 | 2005 | 1791 | 0.070 |
Why?
|
Hospitals, Pediatric | 1 | 2015 | 1775 | 0.070 |
Why?
|
3T3 Cells | 2 | 2009 | 1101 | 0.070 |
Why?
|
Ovalbumin | 2 | 2018 | 719 | 0.070 |
Why?
|
Microarray Analysis | 1 | 2009 | 767 | 0.070 |
Why?
|
Leukemia | 1 | 2014 | 1511 | 0.070 |
Why?
|
State Health Plans | 1 | 2008 | 216 | 0.070 |
Why?
|
Propensity Score | 3 | 2018 | 1781 | 0.070 |
Why?
|
Frameshift Mutation | 1 | 2007 | 399 | 0.070 |
Why?
|
Diagnostic Techniques, Respiratory System | 1 | 2005 | 12 | 0.070 |
Why?
|
Elastin | 2 | 2005 | 308 | 0.070 |
Why?
|
Angina Pectoris | 3 | 1997 | 977 | 0.070 |
Why?
|
Staining and Labeling | 1 | 2010 | 1100 | 0.070 |
Why?
|
Chromosomes, Human, Pair 4 | 3 | 2011 | 374 | 0.070 |
Why?
|
Genetics, Medical | 1 | 2008 | 338 | 0.070 |
Why?
|
Suburban Population | 1 | 2005 | 55 | 0.070 |
Why?
|
Rats, Sprague-Dawley | 4 | 2010 | 8301 | 0.070 |
Why?
|
Hypertriglyceridemia | 2 | 1999 | 293 | 0.070 |
Why?
|
Interleukin-17 | 2 | 2017 | 899 | 0.070 |
Why?
|
Th1 Cells | 3 | 2005 | 1057 | 0.070 |
Why?
|
Cardiomegaly | 2 | 1985 | 620 | 0.070 |
Why?
|
Sulfonamides | 2 | 2013 | 1938 | 0.070 |
Why?
|
Glucose | 2 | 2020 | 4397 | 0.060 |
Why?
|
Long Interspersed Nucleotide Elements | 2 | 2021 | 338 | 0.060 |
Why?
|
Medicaid | 3 | 2008 | 2736 | 0.060 |
Why?
|
Toll-Like Receptors | 3 | 2004 | 592 | 0.060 |
Why?
|
Homozygote | 3 | 2018 | 1785 | 0.060 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2008 | 336 | 0.060 |
Why?
|
Hypnotics and Sedatives | 1 | 1993 | 1162 | 0.060 |
Why?
|
Neovascularization, Pathologic | 1 | 2015 | 2635 | 0.060 |
Why?
|
Motivation | 1 | 1995 | 1971 | 0.060 |
Why?
|
Osteoblasts | 1 | 2011 | 1166 | 0.060 |
Why?
|
Perception | 1 | 1992 | 1198 | 0.060 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2009 | 635 | 0.060 |
Why?
|
Hematopoietic Stem Cells | 3 | 2020 | 3386 | 0.060 |
Why?
|
Organ Specificity | 3 | 2016 | 2008 | 0.060 |
Why?
|
Up-Regulation | 4 | 2018 | 4217 | 0.060 |
Why?
|
Toll-Like Receptor 6 | 1 | 2004 | 28 | 0.060 |
Why?
|
Least-Squares Analysis | 3 | 2017 | 379 | 0.060 |
Why?
|
Toll-Like Receptor 10 | 1 | 2004 | 12 | 0.060 |
Why?
|
Bacterial Proteins | 1 | 1998 | 3848 | 0.060 |
Why?
|
Sequence Deletion | 2 | 2007 | 1526 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-ets | 2 | 2002 | 318 | 0.060 |
Why?
|
Toll-Like Receptor 9 | 2 | 2003 | 212 | 0.060 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2010 | 496 | 0.060 |
Why?
|
Molecular Probes | 2 | 2005 | 316 | 0.060 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2010 | 838 | 0.060 |
Why?
|
Serpins | 1 | 2006 | 247 | 0.060 |
Why?
|
Heart | 2 | 2010 | 4467 | 0.060 |
Why?
|
Catalytic Domain | 2 | 2005 | 698 | 0.060 |
Why?
|
Quebec | 1 | 2004 | 134 | 0.060 |
Why?
|
Random Allocation | 6 | 1994 | 2429 | 0.060 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2006 | 227 | 0.060 |
Why?
|
Contrast Media | 1 | 2018 | 5300 | 0.060 |
Why?
|
Cholesterol | 6 | 2000 | 2917 | 0.060 |
Why?
|
Medical Records | 2 | 2007 | 1413 | 0.060 |
Why?
|
DNA Replication | 2 | 2021 | 1399 | 0.060 |
Why?
|
Microfilament Proteins | 1 | 2010 | 1152 | 0.060 |
Why?
|
Sweden | 2 | 2021 | 1345 | 0.060 |
Why?
|
Cysteine | 1 | 2009 | 874 | 0.060 |
Why?
|
Cost Sharing | 1 | 2008 | 407 | 0.060 |
Why?
|
Siberia | 1 | 2003 | 32 | 0.060 |
Why?
|
Silk | 2 | 2001 | 91 | 0.060 |
Why?
|
Multiple Myeloma | 1 | 2022 | 5181 | 0.060 |
Why?
|
Receptors, Antigen, B-Cell | 2 | 2001 | 548 | 0.060 |
Why?
|
Actins | 1 | 2011 | 2121 | 0.060 |
Why?
|
Histidine | 1 | 2004 | 313 | 0.060 |
Why?
|
Mental Recall | 1 | 1990 | 1205 | 0.060 |
Why?
|
Teaching | 1 | 1992 | 1174 | 0.060 |
Why?
|
Fracture Fixation, Internal | 1 | 2010 | 917 | 0.060 |
Why?
|
Transfection | 4 | 2002 | 5892 | 0.060 |
Why?
|
Energy Transfer | 2 | 2001 | 109 | 0.060 |
Why?
|
Fires | 2 | 1982 | 173 | 0.060 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 1986 | 434 | 0.060 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2010 | 2015 | 0.060 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2010 | 851 | 0.060 |
Why?
|
Peptides | 4 | 2007 | 4409 | 0.060 |
Why?
|
Prostate-Specific Antigen | 2 | 2012 | 2494 | 0.060 |
Why?
|
Occupations | 1 | 1986 | 517 | 0.060 |
Why?
|
Isoleucine | 1 | 2003 | 112 | 0.060 |
Why?
|
Hyperuricemia | 1 | 2006 | 211 | 0.060 |
Why?
|
Workflow | 2 | 2020 | 847 | 0.060 |
Why?
|
Blood Pressure Determination | 2 | 2003 | 634 | 0.060 |
Why?
|
Pseudomonas Infections | 1 | 2008 | 613 | 0.060 |
Why?
|
Kidney | 3 | 2016 | 7186 | 0.060 |
Why?
|
Cloning, Molecular | 3 | 2007 | 4320 | 0.060 |
Why?
|
Green Fluorescent Proteins | 1 | 2009 | 2088 | 0.060 |
Why?
|
Tars | 1 | 1983 | 20 | 0.060 |
Why?
|
Receptor, Cholecystokinin A | 1 | 2023 | 13 | 0.060 |
Why?
|
Rivers | 1 | 2003 | 66 | 0.060 |
Why?
|
alpha 1-Antitrypsin | 2 | 2001 | 164 | 0.060 |
Why?
|
Durapatite | 1 | 2004 | 161 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6538 | 0.060 |
Why?
|
Social Control, Formal | 1 | 1983 | 110 | 0.060 |
Why?
|
School Health Services | 1 | 1987 | 375 | 0.060 |
Why?
|
Bone Marrow | 1 | 2013 | 2948 | 0.060 |
Why?
|
Swine | 2 | 2010 | 5917 | 0.060 |
Why?
|
Anticoagulants | 1 | 2018 | 4599 | 0.060 |
Why?
|
Pyrazoles | 1 | 2013 | 1972 | 0.060 |
Why?
|
Mental Status Schedule | 1 | 2003 | 321 | 0.060 |
Why?
|
Epidemiologic Studies | 2 | 2004 | 676 | 0.060 |
Why?
|
Nebulizers and Vaporizers | 3 | 2008 | 139 | 0.060 |
Why?
|
Imipramine | 2 | 1993 | 97 | 0.060 |
Why?
|
Electroencephalography | 2 | 2013 | 6150 | 0.060 |
Why?
|
Alprazolam | 2 | 1993 | 98 | 0.060 |
Why?
|
Biochemical Phenomena | 1 | 2003 | 59 | 0.050 |
Why?
|
alpha 1-Antitrypsin Deficiency | 2 | 2001 | 107 | 0.050 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 2004 | 369 | 0.050 |
Why?
|
Flow Cytometry | 1 | 2013 | 5974 | 0.050 |
Why?
|
Substance-Related Disorders | 3 | 2007 | 4258 | 0.050 |
Why?
|
Hemochromatosis | 1 | 2004 | 184 | 0.050 |
Why?
|
Ascariasis | 1 | 2002 | 12 | 0.050 |
Why?
|
Action Potentials | 1 | 2010 | 1806 | 0.050 |
Why?
|
Antigens, Plant | 4 | 2004 | 86 | 0.050 |
Why?
|
Axonemal Dyneins | 1 | 2022 | 24 | 0.050 |
Why?
|
Ascaris lumbricoides | 1 | 2002 | 11 | 0.050 |
Why?
|
Capnography | 1 | 2023 | 89 | 0.050 |
Why?
|
Marijuana Abuse | 1 | 1987 | 403 | 0.050 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2002 | 141 | 0.050 |
Why?
|
Adenoma | 1 | 2013 | 2174 | 0.050 |
Why?
|
Prejudice | 1 | 2007 | 570 | 0.050 |
Why?
|
Cholecystokinin | 1 | 2023 | 114 | 0.050 |
Why?
|
Toll-Like Receptor 4 | 2 | 2004 | 565 | 0.050 |
Why?
|
Blood Glucose | 5 | 2005 | 6256 | 0.050 |
Why?
|
Censuses | 1 | 2023 | 200 | 0.050 |
Why?
|
Government Regulation | 1 | 2007 | 522 | 0.050 |
Why?
|
Ceramides | 1 | 2023 | 199 | 0.050 |
Why?
|
Bone Substitutes | 1 | 2004 | 229 | 0.050 |
Why?
|
Lipid Metabolism | 1 | 2011 | 1889 | 0.050 |
Why?
|
Animals, Newborn | 3 | 2015 | 2726 | 0.050 |
Why?
|
Magnetic Resonance Angiography | 1 | 2009 | 1442 | 0.050 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2018 | 768 | 0.050 |
Why?
|
Repressor Proteins | 1 | 2013 | 3023 | 0.050 |
Why?
|
Genes, Recessive | 4 | 2003 | 641 | 0.050 |
Why?
|
Mouth | 2 | 2016 | 374 | 0.050 |
Why?
|
Weight Gain | 2 | 2005 | 2292 | 0.050 |
Why?
|
Infant Food | 1 | 2002 | 141 | 0.050 |
Why?
|
Microscopy, Fluorescence | 1 | 2009 | 2699 | 0.050 |
Why?
|
Muscle, Skeletal | 1 | 1997 | 4931 | 0.050 |
Why?
|
United States Food and Drug Administration | 1 | 2010 | 1584 | 0.050 |
Why?
|
Patient Selection | 1 | 2014 | 4215 | 0.050 |
Why?
|
Inheritance Patterns | 1 | 2004 | 340 | 0.050 |
Why?
|
Anticholesteremic Agents | 2 | 2001 | 979 | 0.050 |
Why?
|
Duty to Recontact | 1 | 2021 | 20 | 0.050 |
Why?
|
Pollen | 3 | 2002 | 75 | 0.050 |
Why?
|
Adjuvants, Immunologic | 1 | 1987 | 1000 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Administration, Intranasal | 2 | 2002 | 446 | 0.050 |
Why?
|
Cost-Benefit Analysis | 5 | 2020 | 5391 | 0.050 |
Why?
|
Respiratory Physiological Phenomena | 2 | 2019 | 188 | 0.050 |
Why?
|
Radiography, Interventional | 1 | 2009 | 1095 | 0.050 |
Why?
|
Hemodynamics | 3 | 2000 | 4199 | 0.050 |
Why?
|
Mice, Obese | 1 | 2023 | 424 | 0.050 |
Why?
|
Cell Communication | 1 | 2009 | 1621 | 0.050 |
Why?
|
Nuclear Matrix | 1 | 2001 | 28 | 0.050 |
Why?
|
Reperfusion Injury | 1 | 2008 | 1026 | 0.050 |
Why?
|
Histamine H1 Antagonists | 1 | 2002 | 100 | 0.050 |
Why?
|
Genetics | 1 | 2002 | 112 | 0.050 |
Why?
|
Memory | 2 | 1998 | 2174 | 0.050 |
Why?
|
Health Behavior | 3 | 2014 | 2636 | 0.050 |
Why?
|
Receptors, Interleukin-2 | 2 | 1995 | 573 | 0.050 |
Why?
|
Communicable Disease Control | 1 | 2008 | 857 | 0.050 |
Why?
|
Iceland | 1 | 2001 | 183 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5853 | 0.050 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2007 | 518 | 0.050 |
Why?
|
Glutamine | 1 | 2004 | 578 | 0.050 |
Why?
|
Pulmonary Diffusing Capacity | 2 | 1980 | 88 | 0.050 |
Why?
|
Child Welfare | 2 | 2004 | 523 | 0.050 |
Why?
|
Myocytes, Cardiac | 1 | 2010 | 1637 | 0.050 |
Why?
|
Recombinant Proteins | 2 | 2010 | 6622 | 0.050 |
Why?
|
Nerve Tissue Proteins | 2 | 2008 | 4462 | 0.050 |
Why?
|
Oregon | 1 | 2001 | 140 | 0.050 |
Why?
|
Active Transport, Cell Nucleus | 2 | 2015 | 443 | 0.050 |
Why?
|
Enzymes | 1 | 2003 | 266 | 0.050 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2004 | 1723 | 0.050 |
Why?
|
Maximal Expiratory Flow Rate | 5 | 1987 | 44 | 0.050 |
Why?
|
Social Change | 2 | 1992 | 153 | 0.050 |
Why?
|
Dyspnea | 4 | 2021 | 1303 | 0.050 |
Why?
|
Emergency Treatment | 2 | 2008 | 517 | 0.050 |
Why?
|
Lovastatin | 1 | 2001 | 120 | 0.050 |
Why?
|
Water Supply | 1 | 1982 | 214 | 0.050 |
Why?
|
Intestinal Mucosa | 1 | 2012 | 3036 | 0.050 |
Why?
|
alpha Karyopherins | 1 | 2020 | 41 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5535 | 0.050 |
Why?
|
Methionine | 1 | 2003 | 590 | 0.050 |
Why?
|
Parasitic Diseases | 1 | 2001 | 75 | 0.050 |
Why?
|
Cell Adhesion | 3 | 2015 | 3144 | 0.050 |
Why?
|
Students | 1 | 1991 | 1654 | 0.050 |
Why?
|
Intensive Care Units | 1 | 2014 | 3679 | 0.050 |
Why?
|
Spiro Compounds | 1 | 2001 | 76 | 0.050 |
Why?
|
Genetic Research | 1 | 2021 | 174 | 0.050 |
Why?
|
Models, Chemical | 1 | 2003 | 626 | 0.050 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2021 | 106 | 0.050 |
Why?
|
Germ-Free Life | 1 | 2021 | 188 | 0.050 |
Why?
|
Personality | 2 | 2002 | 552 | 0.050 |
Why?
|
Helminthiasis, Animal | 1 | 2000 | 7 | 0.050 |
Why?
|
Hyperventilation | 3 | 1986 | 81 | 0.050 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2022 | 314 | 0.050 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2023 | 449 | 0.050 |
Why?
|
Oxygen Consumption | 2 | 2005 | 1869 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2020 | 6487 | 0.050 |
Why?
|
Chemotactic Factors, Eosinophil | 1 | 1999 | 42 | 0.050 |
Why?
|
Sulfotransferases | 1 | 2021 | 151 | 0.050 |
Why?
|
Dysostoses | 1 | 1999 | 9 | 0.050 |
Why?
|
Aspartic Acid Endopeptidases | 2 | 2000 | 311 | 0.050 |
Why?
|
Biopolymers | 1 | 2001 | 189 | 0.050 |
Why?
|
Gene Transfer, Horizontal | 1 | 2020 | 145 | 0.050 |
Why?
|
Helix-Loop-Helix Motifs | 1 | 2000 | 96 | 0.050 |
Why?
|
Cholagogues and Choleretics | 1 | 1999 | 32 | 0.040 |
Why?
|
Fluorine Radioisotopes | 2 | 1994 | 442 | 0.040 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2007 | 1222 | 0.040 |
Why?
|
Hearing Loss, Sensorineural | 2 | 1998 | 770 | 0.040 |
Why?
|
Mental Health | 1 | 2014 | 3019 | 0.040 |
Why?
|
Interleukin-5 | 2 | 2015 | 273 | 0.040 |
Why?
|
Immunosuppressive Agents | 2 | 2010 | 4149 | 0.040 |
Why?
|
Digestive System Diseases | 1 | 2021 | 147 | 0.040 |
Why?
|
Sickness Impact Profile | 1 | 2001 | 302 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2021 | 279 | 0.040 |
Why?
|
Poverty | 4 | 2006 | 2660 | 0.040 |
Why?
|
Fractures, Bone | 1 | 2011 | 1947 | 0.040 |
Why?
|
Functional Residual Capacity | 4 | 2010 | 68 | 0.040 |
Why?
|
Ketorolac | 1 | 1999 | 79 | 0.040 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2020 | 297 | 0.040 |
Why?
|
Germany | 2 | 2014 | 862 | 0.040 |
Why?
|
Denmark | 1 | 2021 | 738 | 0.040 |
Why?
|
Bronchography | 1 | 1999 | 74 | 0.040 |
Why?
|
Pregnancy Trimesters | 1 | 2020 | 192 | 0.040 |
Why?
|
Lymphocyte Activation | 7 | 2006 | 5524 | 0.040 |
Why?
|
Critical Care | 2 | 2022 | 2647 | 0.040 |
Why?
|
Isoproterenol | 3 | 2008 | 399 | 0.040 |
Why?
|
Motor Activity | 2 | 2010 | 2714 | 0.040 |
Why?
|
Panic Disorder | 2 | 1993 | 616 | 0.040 |
Why?
|
Syndrome | 2 | 2004 | 3251 | 0.040 |
Why?
|
Trisaccharides | 1 | 1998 | 50 | 0.040 |
Why?
|
Multiple Sclerosis | 1 | 2014 | 3079 | 0.040 |
Why?
|
Trachea | 2 | 1999 | 1076 | 0.040 |
Why?
|
Quality Assurance, Health Care | 1 | 2009 | 2212 | 0.040 |
Why?
|
Fatty Acids, Volatile | 1 | 2019 | 102 | 0.040 |
Why?
|
Neonatal Screening | 1 | 2003 | 591 | 0.040 |
Why?
|
Diffusion | 1 | 2001 | 833 | 0.040 |
Why?
|
Education, Medical, Continuing | 1 | 2004 | 840 | 0.040 |
Why?
|
Migraine Disorders | 1 | 2011 | 1620 | 0.040 |
Why?
|
Immunohistochemistry | 2 | 2010 | 11366 | 0.040 |
Why?
|
Adolescent Behavior | 1 | 1987 | 1151 | 0.040 |
Why?
|
Technetium Tc 99m Medronate | 1 | 1999 | 136 | 0.040 |
Why?
|
Dioxygenases | 1 | 2020 | 316 | 0.040 |
Why?
|
Colestipol | 1 | 2018 | 10 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2021 | 468 | 0.040 |
Why?
|
Cholestyramine Resin | 1 | 2018 | 24 | 0.040 |
Why?
|
Digestive System | 1 | 1999 | 253 | 0.040 |
Why?
|
Cathepsins | 1 | 1999 | 241 | 0.040 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2021 | 340 | 0.040 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2001 | 659 | 0.040 |
Why?
|
Trans-Activators | 2 | 2020 | 2924 | 0.040 |
Why?
|
Nails | 1 | 2020 | 292 | 0.040 |
Why?
|
Africa | 1 | 2020 | 673 | 0.040 |
Why?
|
T-Lymphocyte Subsets | 2 | 1998 | 1838 | 0.040 |
Why?
|
Terminology as Topic | 2 | 1999 | 1547 | 0.040 |
Why?
|
Clostridium | 1 | 2018 | 98 | 0.040 |
Why?
|
Image Enhancement | 1 | 2009 | 2921 | 0.040 |
Why?
|
Fibric Acids | 1 | 2018 | 25 | 0.040 |
Why?
|
Receptors, LDL | 1 | 2020 | 475 | 0.040 |
Why?
|
Ileum | 1 | 2021 | 565 | 0.040 |
Why?
|
Mosaicism | 1 | 2021 | 441 | 0.040 |
Why?
|
Personality Disorders | 1 | 2003 | 713 | 0.040 |
Why?
|
Adiposity | 1 | 2008 | 1807 | 0.040 |
Why?
|
Pharmacokinetics | 2 | 2010 | 88 | 0.040 |
Why?
|
Terbutaline | 1 | 1997 | 24 | 0.040 |
Why?
|
3-Iodobenzylguanidine | 1 | 1999 | 115 | 0.040 |
Why?
|
Urogenital Abnormalities | 1 | 2021 | 261 | 0.040 |
Why?
|
Inhalation Exposure | 1 | 2001 | 443 | 0.040 |
Why?
|
Minority Groups | 2 | 2022 | 1223 | 0.040 |
Why?
|
Bacteroides | 1 | 2018 | 161 | 0.040 |
Why?
|
Bifidobacterium | 1 | 2018 | 100 | 0.040 |
Why?
|
Milk, Human | 1 | 2022 | 490 | 0.040 |
Why?
|
Quality Control | 1 | 2021 | 841 | 0.040 |
Why?
|
Cost of Illness | 3 | 2002 | 1859 | 0.040 |
Why?
|
Thinness | 1 | 2001 | 480 | 0.040 |
Why?
|
Epigenomics | 1 | 2023 | 903 | 0.040 |
Why?
|
Choice Behavior | 1 | 2004 | 803 | 0.040 |
Why?
|
Drug Therapy, Combination | 6 | 2011 | 6489 | 0.040 |
Why?
|
Parent-Child Relations | 1 | 2002 | 747 | 0.040 |
Why?
|
Secondary Prevention | 1 | 2004 | 1530 | 0.040 |
Why?
|
Rupture, Spontaneous | 1 | 2018 | 354 | 0.040 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2001 | 386 | 0.040 |
Why?
|
Coronary Vessels | 1 | 2009 | 3107 | 0.040 |
Why?
|
Thorax | 1 | 1981 | 547 | 0.040 |
Why?
|
Phosphorylases | 1 | 1997 | 17 | 0.040 |
Why?
|
Ciliary Body | 1 | 1998 | 173 | 0.040 |
Why?
|
Fungi | 1 | 2020 | 327 | 0.040 |
Why?
|
Mammals | 1 | 2023 | 1143 | 0.040 |
Why?
|
Pravastatin | 1 | 2000 | 395 | 0.040 |
Why?
|
Glycogen Storage Disease Type V | 1 | 1997 | 7 | 0.040 |
Why?
|
Pregnancy Outcome | 2 | 2014 | 2795 | 0.040 |
Why?
|
Homeodomain Proteins | 2 | 1998 | 2421 | 0.040 |
Why?
|
Apolipoproteins E | 1 | 2003 | 1438 | 0.040 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1999 | 708 | 0.040 |
Why?
|
Brain | 4 | 2020 | 26385 | 0.040 |
Why?
|
Epidemiology | 1 | 1980 | 287 | 0.040 |
Why?
|
Plant Roots | 1 | 2017 | 109 | 0.040 |
Why?
|
Cell Line, Transformed | 2 | 2015 | 898 | 0.040 |
Why?
|
Liver Transplantation | 1 | 2008 | 2119 | 0.040 |
Why?
|
Meglumine | 1 | 2018 | 149 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 2 | 2019 | 1086 | 0.040 |
Why?
|
Soil Microbiology | 1 | 2017 | 87 | 0.040 |
Why?
|
Anterior Eye Segment | 1 | 1998 | 152 | 0.040 |
Why?
|
Zea mays | 1 | 2017 | 105 | 0.040 |
Why?
|
Pulmonary Ventilation | 5 | 1994 | 373 | 0.040 |
Why?
|
STAT2 Transcription Factor | 1 | 2017 | 27 | 0.040 |
Why?
|
Bile Acids and Salts | 1 | 1999 | 367 | 0.040 |
Why?
|
Fibroma, Desmoplastic | 1 | 1996 | 6 | 0.040 |
Why?
|
Crohn Disease | 1 | 2010 | 2303 | 0.040 |
Why?
|
Bacteroides fragilis | 1 | 2018 | 212 | 0.040 |
Why?
|
Desmosine | 1 | 1996 | 19 | 0.040 |
Why?
|
Cultural Characteristics | 1 | 1999 | 262 | 0.040 |
Why?
|
Gene Targeting | 1 | 2020 | 880 | 0.040 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 1997 | 329 | 0.040 |
Why?
|
Neoplasms | 4 | 2020 | 21683 | 0.040 |
Why?
|
Protein Folding | 1 | 2001 | 843 | 0.040 |
Why?
|
Bone Remodeling | 1 | 2001 | 575 | 0.040 |
Why?
|
Abdomen | 2 | 1994 | 1118 | 0.040 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 2017 | 68 | 0.040 |
Why?
|
Intracellular Fluid | 1 | 1997 | 203 | 0.040 |
Why?
|
Niacin | 1 | 1998 | 116 | 0.040 |
Why?
|
Simvastatin | 1 | 2000 | 360 | 0.040 |
Why?
|
Hydroxyindoleacetic Acid | 2 | 1998 | 90 | 0.040 |
Why?
|
Nucleoproteins | 1 | 1997 | 115 | 0.040 |
Why?
|
Histone Code | 1 | 2017 | 163 | 0.040 |
Why?
|
Infant Formula | 1 | 2018 | 199 | 0.040 |
Why?
|
NAD | 1 | 2020 | 593 | 0.040 |
Why?
|
Islets of Langerhans | 1 | 2003 | 1352 | 0.040 |
Why?
|
Spectrometry, Fluorescence | 1 | 1999 | 689 | 0.040 |
Why?
|
Amino Acids | 1 | 2023 | 1736 | 0.040 |
Why?
|
Health Status Disparities | 1 | 2008 | 1797 | 0.040 |
Why?
|
Clonal Deletion | 1 | 1996 | 79 | 0.040 |
Why?
|
Protease Nexins | 2 | 2006 | 40 | 0.040 |
Why?
|
Radiopharmaceuticals | 2 | 1999 | 2645 | 0.040 |
Why?
|
Open Reading Frames | 2 | 2012 | 810 | 0.040 |
Why?
|
Insurance Coverage | 1 | 2008 | 1901 | 0.040 |
Why?
|
Cell Compartmentation | 1 | 1997 | 402 | 0.040 |
Why?
|
Cations | 1 | 1997 | 232 | 0.030 |
Why?
|
Calcitonin Gene-Related Peptide | 2 | 2008 | 306 | 0.030 |
Why?
|
Stroke | 1 | 2019 | 9981 | 0.030 |
Why?
|
Ferritins | 1 | 2019 | 590 | 0.030 |
Why?
|
Oocytes | 1 | 2021 | 1187 | 0.030 |
Why?
|
Mutation, Missense | 2 | 2023 | 2564 | 0.030 |
Why?
|
Testis | 1 | 2000 | 803 | 0.030 |
Why?
|
Gastrectomy | 1 | 2021 | 663 | 0.030 |
Why?
|
Radiography, Thoracic | 2 | 2000 | 1265 | 0.030 |
Why?
|
Dopamine | 2 | 1994 | 1591 | 0.030 |
Why?
|
Positive-Pressure Respiration | 1 | 2000 | 633 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2003 | 1431 | 0.030 |
Why?
|
Depressive Disorder | 2 | 2009 | 3748 | 0.030 |
Why?
|
Chromosomes, Human, Pair 21 | 1 | 1996 | 230 | 0.030 |
Why?
|
Indoles | 2 | 2002 | 1839 | 0.030 |
Why?
|
Irritants | 1 | 1995 | 44 | 0.030 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 1 | 2015 | 68 | 0.030 |
Why?
|
Heptanoic Acids | 1 | 1998 | 343 | 0.030 |
Why?
|
Self Tolerance | 1 | 1996 | 125 | 0.030 |
Why?
|
Ascorbic Acid Deficiency | 2 | 1998 | 24 | 0.030 |
Why?
|
Amines | 1 | 2017 | 276 | 0.030 |
Why?
|
Uveal Neoplasms | 1 | 1998 | 310 | 0.030 |
Why?
|
Interleukin-4 | 1 | 1999 | 1147 | 0.030 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2019 | 475 | 0.030 |
Why?
|
Energy Intake | 3 | 1992 | 2148 | 0.030 |
Why?
|
Residence Characteristics | 3 | 2001 | 2050 | 0.030 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 1 | 2015 | 27 | 0.030 |
Why?
|
Eosinophil Major Basic Protein | 1 | 2015 | 14 | 0.030 |
Why?
|
Peer Group | 2 | 2005 | 635 | 0.030 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2017 | 286 | 0.030 |
Why?
|
STAT1 Transcription Factor | 1 | 2017 | 320 | 0.030 |
Why?
|
Biocompatible Materials | 1 | 2004 | 1736 | 0.030 |
Why?
|
Pseudogenes | 1 | 1995 | 113 | 0.030 |
Why?
|
Sialic Acids | 1 | 1995 | 127 | 0.030 |
Why?
|
Disclosure | 1 | 2021 | 736 | 0.030 |
Why?
|
United States Department of Veterans Affairs | 2 | 1998 | 875 | 0.030 |
Why?
|
Acute Disease | 7 | 2006 | 7149 | 0.030 |
Why?
|
Fungal Proteins | 1 | 2000 | 912 | 0.030 |
Why?
|
Organ Size | 1 | 2020 | 2252 | 0.030 |
Why?
|
Myocardial Infarction | 6 | 1997 | 11727 | 0.030 |
Why?
|
Tumor Cells, Cultured | 2 | 2001 | 6314 | 0.030 |
Why?
|
Gastroesophageal Reflux | 1 | 2002 | 782 | 0.030 |
Why?
|
Carboxyhemoglobin | 3 | 1992 | 81 | 0.030 |
Why?
|
Specimen Handling | 1 | 2020 | 694 | 0.030 |
Why?
|
Nucleic Acid Conformation | 1 | 1999 | 913 | 0.030 |
Why?
|
Magnetoencephalography | 1 | 1999 | 623 | 0.030 |
Why?
|
Hepatitis, Viral, Animal | 1 | 1995 | 12 | 0.030 |
Why?
|
Radiometry | 1 | 2001 | 800 | 0.030 |
Why?
|
Collagen | 3 | 2001 | 2689 | 0.030 |
Why?
|
Patient Acceptance of Health Care | 1 | 2009 | 3022 | 0.030 |
Why?
|
Cell Size | 1 | 2017 | 643 | 0.030 |
Why?
|
Streptococcus pneumoniae | 1 | 2020 | 714 | 0.030 |
Why?
|
Drug Repositioning | 1 | 2017 | 229 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2013 | 9239 | 0.030 |
Why?
|
Health Status | 1 | 2008 | 4034 | 0.030 |
Why?
|
Mexico | 2 | 2009 | 690 | 0.030 |
Why?
|
Mitogens | 2 | 2005 | 232 | 0.030 |
Why?
|
Informed Consent | 1 | 2021 | 995 | 0.030 |
Why?
|
N-Acetylneuraminic Acid | 1 | 1995 | 177 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2020 | 2187 | 0.030 |
Why?
|
Antigens, CD | 2 | 2006 | 4026 | 0.030 |
Why?
|
Natural Killer T-Cells | 1 | 2018 | 316 | 0.030 |
Why?
|
Chromosomes, Human, Pair 10 | 2 | 2011 | 287 | 0.030 |
Why?
|
Hearing Disorders | 1 | 1975 | 124 | 0.030 |
Why?
|
Inspiratory Capacity | 4 | 1999 | 36 | 0.030 |
Why?
|
Neurons | 3 | 2000 | 9338 | 0.030 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 1995 | 322 | 0.030 |
Why?
|
Rhode Island | 1 | 2015 | 347 | 0.030 |
Why?
|
Apoptosis | 2 | 2009 | 9727 | 0.030 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 1996 | 234 | 0.030 |
Why?
|
Depression | 2 | 2022 | 7766 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2022 | 1526 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2021 | 1813 | 0.030 |
Why?
|
Laryngoscopy | 1 | 2000 | 711 | 0.030 |
Why?
|
Gadolinium DTPA | 1 | 2018 | 836 | 0.030 |
Why?
|
Y Chromosome | 1 | 1995 | 206 | 0.030 |
Why?
|
Magnesium Deficiency | 1 | 1994 | 47 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 1998 | 2540 | 0.030 |
Why?
|
Endosomes | 1 | 1997 | 520 | 0.030 |
Why?
|
Receptors, Interleukin | 1 | 1995 | 245 | 0.030 |
Why?
|
RNA, Small Interfering | 1 | 2023 | 3505 | 0.030 |
Why?
|
National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2014 | 62 | 0.030 |
Why?
|
Nasopharynx | 1 | 2017 | 379 | 0.030 |
Why?
|
Papaverine | 1 | 1973 | 46 | 0.030 |
Why?
|
Republic of Korea | 1 | 2016 | 539 | 0.030 |
Why?
|
Cell Lineage | 2 | 2000 | 2504 | 0.030 |
Why?
|
Drug Delivery Systems | 1 | 2005 | 2219 | 0.030 |
Why?
|
Tacrolimus Binding Proteins | 1 | 2015 | 195 | 0.030 |
Why?
|
Gene Silencing | 1 | 2020 | 1538 | 0.030 |
Why?
|
Recovery of Function | 1 | 2004 | 2925 | 0.030 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2014 | 299 | 0.030 |
Why?
|
Camptothecin | 1 | 2017 | 576 | 0.030 |
Why?
|
Organometallic Compounds | 1 | 2018 | 665 | 0.030 |
Why?
|
Feeding Behavior | 1 | 2006 | 3188 | 0.030 |
Why?
|
Tissue Engineering | 1 | 2004 | 1880 | 0.030 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 1996 | 286 | 0.030 |
Why?
|
Cytosol | 1 | 1997 | 901 | 0.030 |
Why?
|
Taste | 1 | 1995 | 176 | 0.030 |
Why?
|
Thymus Gland | 2 | 1998 | 1267 | 0.030 |
Why?
|
Embryo, Mammalian | 1 | 2000 | 1701 | 0.030 |
Why?
|
Program Development | 1 | 2000 | 1316 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2019 | 1364 | 0.030 |
Why?
|
Spouses | 1 | 1996 | 286 | 0.030 |
Why?
|
Th1-Th2 Balance | 1 | 2013 | 38 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2013 | 6773 | 0.030 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2016 | 406 | 0.030 |
Why?
|
Social Identification | 1 | 1994 | 103 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2010 | 13695 | 0.030 |
Why?
|
Radiography | 2 | 2000 | 7023 | 0.030 |
Why?
|
Gout | 1 | 2000 | 573 | 0.030 |
Why?
|
Patient Discharge | 1 | 2006 | 3313 | 0.030 |
Why?
|
Cognition | 2 | 2003 | 6770 | 0.030 |
Why?
|
Deoxyglucose | 1 | 1994 | 337 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2021 | 8949 | 0.030 |
Why?
|
Health Services Accessibility | 2 | 2008 | 5137 | 0.030 |
Why?
|
Calcium, Dietary | 1 | 1996 | 526 | 0.030 |
Why?
|
Golgi Apparatus | 1 | 1995 | 410 | 0.030 |
Why?
|
Blood Chemical Analysis | 1 | 2015 | 440 | 0.030 |
Why?
|
Viruses | 1 | 2017 | 374 | 0.030 |
Why?
|
Nutrition Surveys | 2 | 2005 | 1660 | 0.030 |
Why?
|
Blotting, Western | 2 | 2011 | 5179 | 0.030 |
Why?
|
Meningitis | 1 | 1995 | 216 | 0.030 |
Why?
|
Interleukin-6 | 2 | 2016 | 3200 | 0.030 |
Why?
|
Drug Synergism | 1 | 2017 | 1792 | 0.030 |
Why?
|
Information Dissemination | 1 | 2021 | 1099 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 2 | 1998 | 2268 | 0.030 |
Why?
|
Cysts | 1 | 1998 | 678 | 0.030 |
Why?
|
Smell | 1 | 1995 | 244 | 0.030 |
Why?
|
Antigens, Viral | 1 | 1997 | 1035 | 0.030 |
Why?
|
Cytochrome P-450 CYP1A1 | 1 | 2012 | 91 | 0.030 |
Why?
|
Rats, Inbred Strains | 2 | 1992 | 2186 | 0.030 |
Why?
|
Cognition Disorders | 1 | 2007 | 4043 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2017 | 783 | 0.030 |
Why?
|
Program Evaluation | 1 | 2021 | 2488 | 0.030 |
Why?
|
Gadolinium | 1 | 2018 | 952 | 0.030 |
Why?
|
Benzimidazoles | 1 | 2018 | 850 | 0.030 |
Why?
|
Rats, Inbred BN | 1 | 2012 | 235 | 0.030 |
Why?
|
Death, Sudden | 1 | 1994 | 302 | 0.030 |
Why?
|
Pyrenes | 1 | 2012 | 46 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 1996 | 805 | 0.030 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2017 | 571 | 0.030 |
Why?
|
Antigens, Bacterial | 1 | 1998 | 1171 | 0.030 |
Why?
|
Survival Rate | 2 | 2006 | 12788 | 0.030 |
Why?
|
SRS-A | 1 | 1992 | 156 | 0.030 |
Why?
|
Xanthines | 1 | 1992 | 121 | 0.030 |
Why?
|
Alcoholic Beverages | 1 | 1994 | 265 | 0.030 |
Why?
|
Thymidylate Synthase | 1 | 2012 | 75 | 0.030 |
Why?
|
Models, Animal | 2 | 2012 | 2171 | 0.030 |
Why?
|
Fetal Organ Maturity | 1 | 1992 | 82 | 0.030 |
Why?
|
Untranslated Regions | 1 | 2012 | 31 | 0.030 |
Why?
|
Sarcosine Dehydrogenase | 1 | 2011 | 5 | 0.030 |
Why?
|
Formate-Tetrahydrofolate Ligase | 1 | 2011 | 5 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2017 | 1880 | 0.030 |
Why?
|
Sp3 Transcription Factor | 1 | 2011 | 29 | 0.030 |
Why?
|
Matched-Pair Analysis | 2 | 2004 | 288 | 0.030 |
Why?
|
Enzyme Induction | 1 | 2012 | 475 | 0.030 |
Why?
|
Cell Division | 1 | 2000 | 4568 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2018 | 35421 | 0.030 |
Why?
|
Pregnancy, Multiple | 1 | 1993 | 217 | 0.030 |
Why?
|
Aminohydrolases | 1 | 2011 | 18 | 0.030 |
Why?
|
Methylenetetrahydrofolate Dehydrogenase (NADP) | 1 | 2011 | 17 | 0.030 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2015 | 638 | 0.030 |
Why?
|
Fetal Membranes, Premature Rupture | 1 | 1993 | 140 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2000 | 2513 | 0.030 |
Why?
|
Equipment Design | 1 | 2000 | 3582 | 0.030 |
Why?
|
X Chromosome | 1 | 1995 | 814 | 0.030 |
Why?
|
Prostatic Hyperplasia | 1 | 1996 | 523 | 0.030 |
Why?
|
Physical Exertion | 2 | 1993 | 695 | 0.030 |
Why?
|
RNA Interference | 1 | 2020 | 2889 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 1995 | 733 | 0.030 |
Why?
|
Proteoglycans | 1 | 2015 | 835 | 0.030 |
Why?
|
Kidney Diseases | 1 | 2003 | 2149 | 0.030 |
Why?
|
Small Molecule Libraries | 1 | 2017 | 720 | 0.030 |
Why?
|
Interprofessional Relations | 1 | 1998 | 1011 | 0.030 |
Why?
|
Point Mutation | 1 | 1997 | 1623 | 0.030 |
Why?
|
Fluconazole | 1 | 1992 | 146 | 0.030 |
Why?
|
France | 1 | 2013 | 517 | 0.020 |
Why?
|
Water | 2 | 1998 | 1395 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2016 | 713 | 0.020 |
Why?
|
Interleukins | 2 | 2008 | 791 | 0.020 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2012 | 257 | 0.020 |
Why?
|
Diarrhea | 1 | 2018 | 1348 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2017 | 944 | 0.020 |
Why?
|
DNA Damage | 1 | 2021 | 2432 | 0.020 |
Why?
|
Hip | 1 | 1992 | 257 | 0.020 |
Why?
|
Desoxycorticosterone | 1 | 1991 | 50 | 0.020 |
Why?
|
Alu Elements | 1 | 2011 | 119 | 0.020 |
Why?
|
Diabetic Neuropathies | 1 | 1975 | 400 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2011 | 300 | 0.020 |
Why?
|
Pyrroles | 1 | 1998 | 1146 | 0.020 |
Why?
|
Personality Inventory | 1 | 1994 | 1030 | 0.020 |
Why?
|
Steroid 11-beta-Hydroxylase | 1 | 1991 | 20 | 0.020 |
Why?
|
Binding Sites | 2 | 2010 | 6114 | 0.020 |
Why?
|
Fractures, Malunited | 1 | 2011 | 82 | 0.020 |
Why?
|
Encephalitis | 1 | 1995 | 423 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2022 | 3462 | 0.020 |
Why?
|
Community Networks | 1 | 2013 | 203 | 0.020 |
Why?
|
Immunoglobulin A | 1 | 1995 | 992 | 0.020 |
Why?
|
Caribbean Region | 1 | 2011 | 194 | 0.020 |
Why?
|
Gene Library | 1 | 2014 | 1074 | 0.020 |
Why?
|
Tubulin | 1 | 1994 | 695 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2003 | 8642 | 0.020 |
Why?
|
Protein Interaction Mapping | 1 | 2015 | 627 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2000 | 2418 | 0.020 |
Why?
|
3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2010 | 56 | 0.020 |
Why?
|
Breast Neoplasms | 3 | 2001 | 20822 | 0.020 |
Why?
|
Rats, Inbred Lew | 1 | 2012 | 1162 | 0.020 |
Why?
|
Neuroblastoma | 1 | 1999 | 1226 | 0.020 |
Why?
|
Sodium, Dietary | 1 | 1994 | 418 | 0.020 |
Why?
|
Osteoporosis | 1 | 2000 | 1580 | 0.020 |
Why?
|
Veterans | 2 | 2003 | 2519 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 1998 | 1504 | 0.020 |
Why?
|
Oligonucleotide Probes | 1 | 1991 | 427 | 0.020 |
Why?
|
Paired-Associate Learning | 1 | 1990 | 52 | 0.020 |
Why?
|
Pulmonary Medicine | 2 | 2006 | 213 | 0.020 |
Why?
|
Simian virus 40 | 1 | 1991 | 295 | 0.020 |
Why?
|
Reimbursement Mechanisms | 1 | 2016 | 670 | 0.020 |
Why?
|
Retinitis Pigmentosa | 1 | 1994 | 386 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2001 | 2266 | 0.020 |
Why?
|
Vitamin B 6 | 1 | 2011 | 237 | 0.020 |
Why?
|
Phosphatidylcholines | 1 | 1992 | 411 | 0.020 |
Why?
|
Body Burden | 2 | 2004 | 158 | 0.020 |
Why?
|
Pandemics | 2 | 2021 | 8388 | 0.020 |
Why?
|
Markov Chains | 2 | 2006 | 969 | 0.020 |
Why?
|
Androstadienes | 1 | 2012 | 346 | 0.020 |
Why?
|
Pulmonary Gas Exchange | 1 | 1992 | 382 | 0.020 |
Why?
|
Heart Block | 2 | 1998 | 410 | 0.020 |
Why?
|
Barbados | 1 | 2009 | 52 | 0.020 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2000 | 1888 | 0.020 |
Why?
|
Intradermal Tests | 2 | 2001 | 44 | 0.020 |
Why?
|
Immunity | 1 | 2016 | 1012 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 1996 | 804 | 0.020 |
Why?
|
Weight Loss | 1 | 2001 | 2622 | 0.020 |
Why?
|
New England | 2 | 2005 | 1022 | 0.020 |
Why?
|
Amniotic Fluid | 1 | 1992 | 370 | 0.020 |
Why?
|
Immunoglobulin M | 1 | 1995 | 1537 | 0.020 |
Why?
|
Steroid Hydroxylases | 1 | 2009 | 96 | 0.020 |
Why?
|
Self Care | 2 | 2006 | 786 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2022 | 3610 | 0.020 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 890 | 0.020 |
Why?
|
Diet Records | 1 | 1991 | 425 | 0.020 |
Why?
|
Societies, Medical | 2 | 2018 | 3743 | 0.020 |
Why?
|
Inhalation | 1 | 2010 | 143 | 0.020 |
Why?
|
Hematologic Neoplasms | 1 | 2021 | 1832 | 0.020 |
Why?
|
Optical Phenomena | 1 | 2009 | 107 | 0.020 |
Why?
|
5' Untranslated Regions | 1 | 2010 | 249 | 0.020 |
Why?
|
Gonadal Steroid Hormones | 2 | 2006 | 712 | 0.020 |
Why?
|
Pulmonary Surfactants | 1 | 2009 | 162 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5078 | 0.020 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2011 | 350 | 0.020 |
Why?
|
Data Compression | 1 | 2009 | 70 | 0.020 |
Why?
|
Biophysical Phenomena | 1 | 2009 | 327 | 0.020 |
Why?
|
Nerve Regeneration | 1 | 1994 | 788 | 0.020 |
Why?
|
Anesthesia | 1 | 2000 | 1561 | 0.020 |
Why?
|
Morals | 1 | 1992 | 284 | 0.020 |
Why?
|
Antigens, Ly | 1 | 2010 | 291 | 0.020 |
Why?
|
Mitomycins | 1 | 1988 | 47 | 0.020 |
Why?
|
Polymorphism, Restriction Fragment Length | 2 | 2004 | 768 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2016 | 2216 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2011 | 893 | 0.020 |
Why?
|
Anxiety Disorders | 2 | 1998 | 2690 | 0.020 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 1993 | 500 | 0.020 |
Why?
|
Patient Education as Topic | 2 | 2013 | 2278 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2003 | 3336 | 0.020 |
Why?
|
Twins, Dizygotic | 1 | 1989 | 236 | 0.020 |
Why?
|
RNA, Untranslated | 1 | 2012 | 453 | 0.020 |
Why?
|
Autoimmunity | 1 | 1996 | 1349 | 0.020 |
Why?
|
Sodium Chloride | 1 | 1991 | 625 | 0.020 |
Why?
|
Stereoisomerism | 1 | 2009 | 624 | 0.020 |
Why?
|
Carbon | 1 | 2012 | 687 | 0.020 |
Why?
|
Tuberculosis, Pulmonary | 2 | 1993 | 810 | 0.020 |
Why?
|
COS Cells | 1 | 2010 | 1161 | 0.020 |
Why?
|
Pregnenediones | 1 | 1988 | 29 | 0.020 |
Why?
|
Spectrometry, X-Ray Emission | 2 | 2001 | 144 | 0.020 |
Why?
|
Echocardiography | 1 | 2021 | 5102 | 0.020 |
Why?
|
Adrenal Glands | 1 | 1991 | 546 | 0.020 |
Why?
|
Hemoglobins | 3 | 2010 | 1534 | 0.020 |
Why?
|
Multienzyme Complexes | 1 | 2011 | 686 | 0.020 |
Why?
|
Dinoprostone | 1 | 2011 | 600 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2011 | 2645 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2020 | 4554 | 0.020 |
Why?
|
Frail Elderly | 1 | 1993 | 693 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 1996 | 1988 | 0.020 |
Why?
|
Sex Ratio | 1 | 2008 | 110 | 0.020 |
Why?
|
Coffee | 1 | 1992 | 578 | 0.020 |
Why?
|
Viral Load | 1 | 2017 | 3299 | 0.020 |
Why?
|
Registries | 2 | 2020 | 8089 | 0.020 |
Why?
|
Paracrine Communication | 1 | 2009 | 277 | 0.020 |
Why?
|
Seasons | 1 | 1993 | 1493 | 0.020 |
Why?
|
Electronics | 1 | 2009 | 322 | 0.020 |
Why?
|
Research | 1 | 2016 | 1999 | 0.020 |
Why?
|
Collagen Type I | 2 | 2001 | 592 | 0.020 |
Why?
|
Mitomycin | 1 | 1988 | 259 | 0.020 |
Why?
|
Twins | 1 | 1989 | 339 | 0.020 |
Why?
|
Bone Plates | 1 | 2010 | 468 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 1988 | 11524 | 0.020 |
Why?
|
Twins, Monozygotic | 1 | 1989 | 458 | 0.020 |
Why?
|
Cell Membrane | 1 | 1997 | 3748 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 2 | 2006 | 1683 | 0.020 |
Why?
|
Health | 1 | 2010 | 394 | 0.020 |
Why?
|
Models, Econometric | 1 | 2008 | 218 | 0.020 |
Why?
|
Occupational Exposure | 1 | 1997 | 1796 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2016 | 4204 | 0.020 |
Why?
|
Dietary Fiber | 1 | 1991 | 760 | 0.020 |
Why?
|
Length of Stay | 1 | 2020 | 6309 | 0.020 |
Why?
|
Goblet Cells | 1 | 2010 | 287 | 0.020 |
Why?
|
Biopsy | 1 | 2019 | 6756 | 0.020 |
Why?
|
Health Care Costs | 1 | 2000 | 3209 | 0.020 |
Why?
|
Complement C5 | 2 | 1997 | 112 | 0.020 |
Why?
|
Postpartum Period | 1 | 1993 | 1086 | 0.020 |
Why?
|
Informatics | 1 | 2007 | 72 | 0.020 |
Why?
|
Survival Analysis | 2 | 2000 | 10252 | 0.020 |
Why?
|
Vinblastine | 1 | 1988 | 502 | 0.020 |
Why?
|
Drug Combinations | 1 | 2012 | 1959 | 0.020 |
Why?
|
Hyperplasia | 1 | 2010 | 1185 | 0.020 |
Why?
|
Compliance | 1 | 2006 | 104 | 0.020 |
Why?
|
Hydralazine | 1 | 1986 | 38 | 0.020 |
Why?
|
Glucocorticoid-Induced TNFR-Related Protein | 1 | 2006 | 42 | 0.020 |
Why?
|
Australia | 1 | 2009 | 1170 | 0.020 |
Why?
|
Crosses, Genetic | 2 | 1998 | 791 | 0.020 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2007 | 349 | 0.020 |
Why?
|
Residual Volume | 2 | 1988 | 41 | 0.020 |
Why?
|
Heart Conduction System | 2 | 1998 | 1047 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2013 | 1534 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2008 | 617 | 0.020 |
Why?
|
Diet Surveys | 1 | 1990 | 1173 | 0.020 |
Why?
|
Zinc | 1 | 1990 | 684 | 0.020 |
Why?
|
Tropoelastin | 1 | 2005 | 29 | 0.020 |
Why?
|
Withholding Treatment | 1 | 2010 | 599 | 0.020 |
Why?
|
Environmental Monitoring | 1 | 2012 | 1414 | 0.020 |
Why?
|
Insurance | 1 | 2007 | 111 | 0.020 |
Why?
|
5' Flanking Region | 1 | 2005 | 31 | 0.020 |
Why?
|
RNA Stability | 1 | 2007 | 321 | 0.020 |
Why?
|
Administration, Topical | 2 | 2003 | 690 | 0.020 |
Why?
|
Polysorbates | 1 | 2005 | 41 | 0.020 |
Why?
|
Pulmonary Surfactant-Associated Protein B | 1 | 2005 | 42 | 0.020 |
Why?
|
Escherichia coli | 1 | 2017 | 4217 | 0.020 |
Why?
|
Croup | 1 | 1985 | 23 | 0.020 |
Why?
|
Minnesota | 1 | 1986 | 344 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2009 | 1547 | 0.020 |
Why?
|
Lung Neoplasms | 3 | 1987 | 13102 | 0.020 |
Why?
|
Brain Death | 1 | 2008 | 348 | 0.020 |
Why?
|
Clinical Medicine | 1 | 2006 | 147 | 0.020 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 1 | 2006 | 159 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2014 | 2503 | 0.020 |
Why?
|
Allergy and Immunology | 1 | 2006 | 169 | 0.020 |
Why?
|
Michigan | 1 | 1986 | 350 | 0.020 |
Why?
|
Metered Dose Inhalers | 1 | 2004 | 23 | 0.020 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2006 | 200 | 0.020 |
Why?
|
Pain | 1 | 2000 | 4986 | 0.020 |
Why?
|
Accidental Falls | 1 | 1993 | 1062 | 0.020 |
Why?
|
Counseling | 1 | 2013 | 1523 | 0.020 |
Why?
|
Quality of Health Care | 2 | 2003 | 4371 | 0.020 |
Why?
|
Puberty | 1 | 2008 | 490 | 0.020 |
Why?
|
Epoxy Compounds | 1 | 2005 | 136 | 0.020 |
Why?
|
Lipid A | 1 | 2004 | 67 | 0.020 |
Why?
|
Phytohemagglutinins | 1 | 2004 | 170 | 0.020 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 2005 | 171 | 0.020 |
Why?
|
Desipramine | 1 | 2004 | 184 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2017 | 2987 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2012 | 1738 | 0.020 |
Why?
|
Connecticut | 1 | 2005 | 366 | 0.020 |
Why?
|
Protein Binding | 1 | 2017 | 9386 | 0.020 |
Why?
|
Treatment Refusal | 1 | 2008 | 421 | 0.020 |
Why?
|
Chromosomes, Human, Pair 11 | 2 | 1997 | 417 | 0.020 |
Why?
|
Epoxide Hydrolases | 1 | 2005 | 122 | 0.020 |
Why?
|
Leukemia, Lymphoid | 1 | 1984 | 315 | 0.010 |
Why?
|
Eating | 1 | 1991 | 1536 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2015 | 2916 | 0.010 |
Why?
|
Income | 3 | 2000 | 1913 | 0.010 |
Why?
|
Bronchial Fistula | 1 | 1984 | 85 | 0.010 |
Why?
|
Erythroid-Specific DNA-Binding Factors | 1 | 2003 | 198 | 0.010 |
Why?
|
Mixed Function Oxygenases | 1 | 2005 | 272 | 0.010 |
Why?
|
Diagnosis | 1 | 1964 | 154 | 0.010 |
Why?
|
Microtubules | 1 | 2009 | 1090 | 0.010 |
Why?
|
Endocytosis | 1 | 2008 | 985 | 0.010 |
Why?
|
Particulate Matter | 1 | 2015 | 2530 | 0.010 |
Why?
|
YY1 Transcription Factor | 1 | 2003 | 60 | 0.010 |
Why?
|
Reaction Time | 1 | 1990 | 2097 | 0.010 |
Why?
|
Postoperative Period | 1 | 2008 | 1842 | 0.010 |
Why?
|
Sinusitis | 1 | 1992 | 923 | 0.010 |
Why?
|
Apolipoprotein E3 | 1 | 2003 | 97 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2006 | 595 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2015 | 1917 | 0.010 |
Why?
|
Apolipoprotein E2 | 1 | 2003 | 127 | 0.010 |
Why?
|
Disability Evaluation | 1 | 1990 | 1827 | 0.010 |
Why?
|
Animals, Domestic | 1 | 2002 | 56 | 0.010 |
Why?
|
Rheumatoid Nodule | 1 | 1982 | 15 | 0.010 |
Why?
|
Infant Equipment | 1 | 2002 | 24 | 0.010 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2005 | 798 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 2006 | 927 | 0.010 |
Why?
|
Osseointegration | 1 | 2004 | 276 | 0.010 |
Why?
|
Myocardium | 1 | 2016 | 4776 | 0.010 |
Why?
|
Flucytosine | 1 | 1982 | 32 | 0.010 |
Why?
|
Neurotoxins | 1 | 2003 | 237 | 0.010 |
Why?
|
Mycobacterium tuberculosis | 1 | 1993 | 1832 | 0.010 |
Why?
|
Urban Health | 1 | 2005 | 547 | 0.010 |
Why?
|
Public Policy | 1 | 1987 | 572 | 0.010 |
Why?
|
Skin | 1 | 2016 | 4364 | 0.010 |
Why?
|
Selenium | 1 | 2005 | 405 | 0.010 |
Why?
|
Phenylcarbamates | 1 | 2002 | 38 | 0.010 |
Why?
|
Macrophages | 1 | 1997 | 5655 | 0.010 |
Why?
|
Fistula | 1 | 1984 | 220 | 0.010 |
Why?
|
Lung Abscess | 1 | 1982 | 42 | 0.010 |
Why?
|
Health Benefit Plans, Employee | 1 | 2005 | 332 | 0.010 |
Why?
|
Neuropsychological Tests | 2 | 1998 | 6993 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 2005 | 13815 | 0.010 |
Why?
|
Alternaria | 1 | 2002 | 44 | 0.010 |
Why?
|
Amphotericin B | 1 | 1982 | 137 | 0.010 |
Why?
|
Hematocrit | 1 | 1983 | 636 | 0.010 |
Why?
|
Tosyl Compounds | 1 | 2002 | 113 | 0.010 |
Why?
|
Clinical Protocols | 1 | 1988 | 1462 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2009 | 1917 | 0.010 |
Why?
|
Aphakia, Postcataract | 1 | 1982 | 54 | 0.010 |
Why?
|
Immune System Diseases | 1 | 2004 | 262 | 0.010 |
Why?
|
Isotope Labeling | 2 | 1994 | 406 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2007 | 6038 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2008 | 2539 | 0.010 |
Why?
|
Medical History Taking | 1 | 2005 | 783 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2000 | 3870 | 0.010 |
Why?
|
Vision Tests | 1 | 1982 | 167 | 0.010 |
Why?
|
Genetic Vectors | 1 | 1991 | 3420 | 0.010 |
Why?
|
Organizational Innovation | 1 | 2004 | 559 | 0.010 |
Why?
|
Phantoms, Imaging | 1 | 2009 | 2480 | 0.010 |
Why?
|
Particle Size | 1 | 2005 | 1642 | 0.010 |
Why?
|
Cytosine | 1 | 1982 | 216 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2004 | 1590 | 0.010 |
Why?
|
Fluoxetine | 1 | 2004 | 749 | 0.010 |
Why?
|
Materials Testing | 1 | 2004 | 867 | 0.010 |
Why?
|
Cytoplasm | 1 | 2005 | 1539 | 0.010 |
Why?
|
Arthritis, Rheumatoid | 2 | 2009 | 3712 | 0.010 |
Why?
|
Norway | 1 | 2001 | 448 | 0.010 |
Why?
|
Diagnosis, Differential | 3 | 2008 | 12959 | 0.010 |
Why?
|
Total Lung Capacity | 1 | 1980 | 143 | 0.010 |
Why?
|
Cardiovascular Agents | 1 | 2007 | 850 | 0.010 |
Why?
|
Osteocalcin | 1 | 2001 | 273 | 0.010 |
Why?
|
Recreation | 1 | 2001 | 115 | 0.010 |
Why?
|
Health Services | 1 | 2005 | 758 | 0.010 |
Why?
|
Employment | 1 | 2007 | 1132 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 1993 | 2400 | 0.010 |
Why?
|
Isoenzymes | 1 | 2005 | 1726 | 0.010 |
Why?
|
Models, Immunological | 1 | 2002 | 527 | 0.010 |
Why?
|
Antigens | 1 | 2006 | 1466 | 0.010 |
Why?
|
Family Characteristics | 1 | 2005 | 1000 | 0.010 |
Why?
|
Naloxone | 1 | 1982 | 367 | 0.010 |
Why?
|
Melanoma | 1 | 1998 | 5510 | 0.010 |
Why?
|
Mice, Transgenic | 3 | 1998 | 9734 | 0.010 |
Why?
|
Tomography, Emission-Computed | 2 | 1994 | 1144 | 0.010 |
Why?
|
Cathepsin K | 1 | 1999 | 68 | 0.010 |
Why?
|
Attention | 1 | 1990 | 2400 | 0.010 |
Why?
|
Cell Aggregation | 1 | 2000 | 244 | 0.010 |
Why?
|
Candidiasis | 1 | 1982 | 366 | 0.010 |
Why?
|
Micrognathism | 1 | 1999 | 57 | 0.010 |
Why?
|
Drug Hypersensitivity | 1 | 1988 | 884 | 0.010 |
Why?
|
Cattle | 1 | 2005 | 3922 | 0.010 |
Why?
|
Testosterone | 2 | 2000 | 2420 | 0.010 |
Why?
|
Acarbose | 1 | 1998 | 10 | 0.010 |
Why?
|
Apolipoprotein E4 | 1 | 2003 | 668 | 0.010 |
Why?
|
Tacrolimus | 1 | 2003 | 743 | 0.010 |
Why?
|
Tissue Donors | 1 | 2008 | 2240 | 0.010 |
Why?
|
Therapeutic Equivalency | 1 | 1999 | 141 | 0.010 |
Why?
|
Adipocytes | 1 | 2006 | 1184 | 0.010 |
Why?
|
Nucleic Acid Denaturation | 1 | 1999 | 111 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 2004 | 2029 | 0.010 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2000 | 285 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 1995 | 2649 | 0.010 |
Why?
|
Health Status Indicators | 1 | 2004 | 969 | 0.010 |
Why?
|
Tissue Distribution | 2 | 1994 | 2327 | 0.010 |
Why?
|
Stromal Cells | 1 | 2004 | 1355 | 0.010 |
Why?
|
Spermatogenesis | 1 | 2000 | 262 | 0.010 |
Why?
|
Vehicle Emissions | 1 | 1983 | 665 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2009 | 2759 | 0.010 |
Why?
|
Helium | 2 | 1990 | 123 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 2000 | 643 | 0.010 |
Why?
|
Growth | 1 | 2000 | 376 | 0.010 |
Why?
|
Transcription Factor Brn-3C | 1 | 1998 | 12 | 0.010 |
Why?
|
Aerosols | 2 | 1993 | 625 | 0.010 |
Why?
|
Sulfur Dioxide | 1 | 1998 | 177 | 0.010 |
Why?
|
Spleen | 1 | 2004 | 2362 | 0.010 |
Why?
|
Labor, Obstetric | 1 | 1981 | 333 | 0.010 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 1998 | 318 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2014 | 16689 | 0.010 |
Why?
|
Leptin | 1 | 2006 | 1599 | 0.010 |
Why?
|
Neurofilament Proteins | 1 | 2000 | 318 | 0.010 |
Why?
|
Medical Record Linkage | 1 | 1999 | 284 | 0.010 |
Why?
|
Ammonium Chloride | 1 | 1997 | 74 | 0.010 |
Why?
|
Hip Fractures | 1 | 2006 | 955 | 0.010 |
Why?
|
Mice, Inbred A | 1 | 1997 | 248 | 0.010 |
Why?
|
Immunologic Memory | 1 | 2004 | 1348 | 0.010 |
Why?
|
Surface Properties | 1 | 1980 | 1184 | 0.010 |
Why?
|
Vocabulary | 1 | 1998 | 169 | 0.010 |
Why?
|
Postprandial Period | 1 | 1998 | 292 | 0.010 |
Why?
|
Otitis Media | 1 | 1999 | 277 | 0.010 |
Why?
|
Osteogenesis | 1 | 2004 | 1299 | 0.010 |
Why?
|
Phosphorylation | 1 | 2008 | 8436 | 0.010 |
Why?
|
Phosphates | 1 | 2000 | 786 | 0.010 |
Why?
|
Urea | 1 | 1999 | 450 | 0.010 |
Why?
|
Capillary Permeability | 1 | 1980 | 798 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 1998 | 683 | 0.010 |
Why?
|
Clinical Pharmacy Information Systems | 1 | 1997 | 103 | 0.010 |
Why?
|
Spectrophotometry, Atomic | 1 | 1996 | 81 | 0.010 |
Why?
|
Social Conditions | 1 | 1997 | 126 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2004 | 1678 | 0.010 |
Why?
|
Body Temperature | 1 | 1999 | 777 | 0.010 |
Why?
|
Health Services Research | 1 | 2004 | 1836 | 0.010 |
Why?
|
Decision Making | 1 | 1990 | 3887 | 0.010 |
Why?
|
Receptors, Interleukin-9 | 1 | 1995 | 4 | 0.010 |
Why?
|
Pulmonary Fibrosis | 1 | 1980 | 530 | 0.010 |
Why?
|
Random Amplified Polymorphic DNA Technique | 1 | 1995 | 19 | 0.010 |
Why?
|
Organ Culture Techniques | 1 | 1998 | 813 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 2017 | 8037 | 0.010 |
Why?
|
Prednisone | 1 | 2000 | 1574 | 0.010 |
Why?
|
Human Growth Hormone | 1 | 2001 | 683 | 0.010 |
Why?
|
Spermatozoa | 1 | 2000 | 625 | 0.010 |
Why?
|
Cataract | 1 | 1982 | 834 | 0.010 |
Why?
|
Pulmonary Artery | 1 | 1984 | 1912 | 0.010 |
Why?
|
Life Change Events | 1 | 2001 | 938 | 0.010 |
Why?
|
Hair Cells, Auditory | 1 | 1998 | 361 | 0.010 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 1 | 1995 | 143 | 0.010 |
Why?
|
Chronobiology Phenomena | 1 | 1995 | 30 | 0.010 |
Why?
|
Photic Stimulation | 1 | 1982 | 2025 | 0.010 |
Why?
|
Hybrid Cells | 1 | 1995 | 441 | 0.010 |
Why?
|
Vestibulocochlear Nerve | 1 | 1975 | 116 | 0.010 |
Why?
|
Retirement | 1 | 1996 | 215 | 0.010 |
Why?
|
Photons | 1 | 1999 | 588 | 0.010 |
Why?
|
Parasympathetic Nervous System | 1 | 1995 | 141 | 0.010 |
Why?
|
Middle East | 1 | 1995 | 219 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 1998 | 1246 | 0.010 |
Why?
|
Albuminuria | 1 | 1998 | 682 | 0.010 |
Why?
|
Blotting, Southern | 1 | 1995 | 803 | 0.010 |
Why?
|
Giant Cells | 1 | 1995 | 187 | 0.010 |
Why?
|
Audiometry | 1 | 1975 | 241 | 0.010 |
Why?
|
Life Style | 1 | 2006 | 3835 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2007 | 3068 | 0.010 |
Why?
|
Social Behavior | 1 | 2001 | 1127 | 0.010 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 1995 | 354 | 0.010 |
Why?
|
Long QT Syndrome | 1 | 1998 | 453 | 0.010 |
Why?
|
Ventilation-Perfusion Ratio | 1 | 1973 | 116 | 0.010 |
Why?
|
Partial Pressure | 1 | 1973 | 254 | 0.010 |
Why?
|
Pulse | 1 | 1973 | 229 | 0.010 |
Why?
|
Spinal Fractures | 1 | 2000 | 696 | 0.010 |
Why?
|
Antigen-Presenting Cells | 1 | 1997 | 973 | 0.010 |
Why?
|
Rodentia | 1 | 1995 | 261 | 0.010 |
Why?
|
New York City | 1 | 1995 | 710 | 0.010 |
Why?
|
Switzerland | 1 | 1993 | 255 | 0.010 |
Why?
|
Neuroimmunomodulation | 1 | 1995 | 157 | 0.010 |
Why?
|
Remission Induction | 1 | 1999 | 2386 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 1996 | 11124 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 1995 | 645 | 0.010 |
Why?
|
Bacterial Typing Techniques | 1 | 1993 | 256 | 0.010 |
Why?
|
Estradiol | 1 | 2000 | 2020 | 0.010 |
Why?
|
Speech | 1 | 1998 | 540 | 0.010 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 1994 | 236 | 0.010 |
Why?
|
Agoraphobia | 1 | 1993 | 179 | 0.010 |
Why?
|
Blood Gas Analysis | 1 | 1973 | 383 | 0.010 |
Why?
|
Antidepressive Agents | 1 | 2004 | 2838 | 0.010 |
Why?
|
Caregivers | 1 | 2004 | 2094 | 0.010 |
Why?
|
Consanguinity | 1 | 1994 | 454 | 0.010 |
Why?
|
Adenine | 1 | 1997 | 936 | 0.010 |
Why?
|
Vitamin A | 1 | 1995 | 615 | 0.010 |
Why?
|
Pattern Recognition, Visual | 1 | 1998 | 824 | 0.010 |
Why?
|
Curriculum | 1 | 1985 | 3605 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 1973 | 1420 | 0.010 |
Why?
|
Morbidity | 1 | 1997 | 1769 | 0.010 |
Why?
|
Decision Support Techniques | 1 | 2001 | 1956 | 0.010 |
Why?
|
Brachytherapy | 1 | 1998 | 1248 | 0.010 |
Why?
|
Patient Dropouts | 1 | 1993 | 421 | 0.010 |
Why?
|
Telomere | 1 | 1996 | 910 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 1995 | 1758 | 0.010 |
Why?
|
Nurses | 1 | 1999 | 2461 | 0.010 |
Why?
|
Developing Countries | 1 | 2002 | 2815 | 0.010 |
Why?
|
Cause of Death | 1 | 2000 | 3584 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 1998 | 1901 | 0.010 |
Why?
|
Neuroglia | 1 | 1994 | 927 | 0.010 |
Why?
|
Medically Uninsured | 1 | 1995 | 853 | 0.010 |
Why?
|
Seroepidemiologic Studies | 1 | 1990 | 401 | 0.010 |
Why?
|
DNA, Bacterial | 1 | 1993 | 1465 | 0.010 |
Why?
|
Education, Medical | 1 | 1980 | 1721 | 0.000 |
Why?
|
Maximal Expiratory Flow-Volume Curves | 1 | 1987 | 25 | 0.000 |
Why?
|
Arizona | 1 | 1987 | 108 | 0.000 |
Why?
|
Child, Hospitalized | 1 | 1989 | 174 | 0.000 |
Why?
|
Substance Withdrawal Syndrome | 1 | 1993 | 632 | 0.000 |
Why?
|
Diabetes Complications | 1 | 1975 | 1359 | 0.000 |
Why?
|
Macaca mulatta | 1 | 1994 | 2375 | 0.000 |
Why?
|
Dietary Carbohydrates | 1 | 1992 | 906 | 0.000 |
Why?
|
Methods | 1 | 1987 | 1129 | 0.000 |
Why?
|
Dietary Proteins | 1 | 1992 | 963 | 0.000 |
Why?
|
Blood Platelets | 1 | 1998 | 2508 | 0.000 |
Why?
|
Sleep | 1 | 2002 | 4623 | 0.000 |
Why?
|
Pilot Projects | 1 | 1999 | 8324 | 0.000 |
Why?
|
Bacteriophage lambda | 1 | 1986 | 147 | 0.000 |
Why?
|
Atrial Fibrillation | 1 | 1964 | 5034 | 0.000 |
Why?
|
DNA, Recombinant | 1 | 1986 | 476 | 0.000 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 1994 | 2016 | 0.000 |
Why?
|
Rabbits | 1 | 1992 | 4894 | 0.000 |
Why?
|
Neoplasm Metastasis | 1 | 1996 | 4851 | 0.000 |
Why?
|
Ultrasonography | 1 | 1998 | 5985 | 0.000 |
Why?
|
Hybridomas | 1 | 1986 | 452 | 0.000 |
Why?
|
Histocompatibility Antigens | 1 | 1986 | 471 | 0.000 |
Why?
|
Intestinal Absorption | 1 | 1965 | 420 | 0.000 |
Why?
|
Nucleic Acid Hybridization | 1 | 1986 | 1375 | 0.000 |
Why?
|
Neoplasm Staging | 1 | 1999 | 11031 | 0.000 |
Why?
|
Brain Mapping | 1 | 1999 | 6669 | 0.000 |
Why?
|
Brugada Syndrome | 1 | 1964 | 97 | 0.000 |
Why?
|
Endorphins | 1 | 1982 | 75 | 0.000 |
Why?
|
Carcinoma, Bronchogenic | 1 | 1982 | 87 | 0.000 |
Why?
|
Oxygen | 2 | 1987 | 4189 | 0.000 |
Why?
|
Insurance, Health | 1 | 1995 | 2494 | 0.000 |
Why?
|
Clone Cells | 1 | 1986 | 1692 | 0.000 |
Why?
|
Physicians | 1 | 1980 | 4567 | 0.000 |
Why?
|
Exercise Test | 1 | 1989 | 2074 | 0.000 |
Why?
|
Premedication | 1 | 1982 | 258 | 0.000 |
Why?
|
Health Promotion | 1 | 1993 | 2205 | 0.000 |
Why?
|
Pharyngitis | 1 | 1982 | 215 | 0.000 |
Why?
|
Embolism, Amniotic Fluid | 1 | 1980 | 19 | 0.000 |
Why?
|
Hair | 1 | 1983 | 483 | 0.000 |
Why?
|
Eyeglasses | 1 | 1982 | 145 | 0.000 |
Why?
|
Lenses, Intraocular | 1 | 1982 | 140 | 0.000 |
Why?
|
Nucleotides, Cyclic | 1 | 1980 | 81 | 0.000 |
Why?
|
Prostaglandins | 1 | 1980 | 405 | 0.000 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 1986 | 1821 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2000 | 20129 | 0.000 |
Why?
|
Exercise | 1 | 1993 | 5615 | 0.000 |
Why?
|
Progesterone | 1 | 1980 | 776 | 0.000 |
Why?
|
Sarcoidosis | 1 | 1980 | 506 | 0.000 |
Why?
|
Visual Acuity | 1 | 1982 | 2530 | 0.000 |
Why?
|
Estrogens | 1 | 1980 | 1566 | 0.000 |
Why?
|
Pulmonary Embolism | 1 | 1980 | 2376 | 0.000 |
Why?
|
Iron Isotopes | 1 | 1965 | 19 | 0.000 |
Why?
|